ArkaAcharya
commited on
Commit
•
51fe376
1
Parent(s):
5a39223
Upload neuroscience with huggingface_hub
Browse files- neuroscience/cleaned.csv +22 -0
- neuroscience/corpus.csv +174 -0
- neuroscience/images/Figure 1.1.jpg +3 -0
- neuroscience/images/Figure 1.2.jpg +3 -0
- neuroscience/images/Figure 1.3.jpg +3 -0
- neuroscience/images/Figure 2.1.jpg +3 -0
- neuroscience/images/Figure 2.2.jpg +3 -0
- neuroscience/images/Figure 2.3.jpg +3 -0
- neuroscience/images/Figure 2.4.jpg +3 -0
- neuroscience/images/Figure 2.5.jpg +3 -0
- neuroscience/images/Figure 2.6.jpg +3 -0
- neuroscience/images/Figure 2.7.jpg +3 -0
- neuroscience/images/Figure 2.8.jpg +3 -0
- neuroscience/images/Figure 2.9.jpg +3 -0
- neuroscience/images/Figure 4.1.jpg +3 -0
- neuroscience/images/Figure 4.3.jpg +3 -0
- neuroscience/images/Figure 4.4.jpg +3 -0
- neuroscience/images/Figure 4.6.jpg +3 -0
- neuroscience/queries.csv +22 -0
- neuroscience/scores.csv +130 -0
neuroscience/cleaned.csv
ADDED
@@ -0,0 +1,22 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
fig_num,image_path,image_caption,golden_corpus,positive_corpus
|
2 |
+
Figure 4.1,neuroscience/images/Figure 4.1.jpg,Figure 4.1: Metabolism of phenylalanine requires BH4 and also produces tyrosine. Deficiencies in cofactor or phenylalanine hydroxylase can result in phenylketonuria.,"Phenylalanine (Phe) is an essential amino acid, and hydroxylation of Phe by phenylalanine hydroxylase (PAH) generates tyrosine (figure 4.1). This conversion requires BH4, and deficiencies in either the cofactor or the enzyme PAH can result in phenylketonuria. Additionally, the inability to synthesize tyrosine will make this a conditionally essential amino acid and potentially negatively impact the synthesis of downstream compounds illustrated in figure 4.2.","{'78effb87-80dd-42a6-940d-801ba33f16f9': 'Phenylalanine (Phe) is an essential amino acid, and hydroxylation of Phe by phenylalanine hydroxylase (PAH) generates tyrosine (figure 4.1). This conversion requires BH4, and deficiencies in either the cofactor or the enzyme PAH can result in phenylketonuria. Additionally, the inability to synthesize tyrosine will make this a conditionally essential amino acid and potentially negatively impact the synthesis of downstream compounds illustrated in figure 4.2.', '6778e5ab-6768-4fae-86c7-ee2b6de8164c': 'Tyrosine can be produced from phenylalanine metabolism and is required for the production of melanin and the catecholamines. Deficiencies can occur at several different locations in the pathway and result in albinism (tyrosinase), alkaptonuria (homogentisate oxidase), or tyrosinemia, which can manifest due to deficiencies in several enzymes along the pathway (figure 4.1).'}"
|
3 |
+
Figure 4.3,neuroscience/images/Figure 4.3.jpg,Figure 4.3: Metabolism of tryptophan to melatonin.,"Tryptophan is an essential amino acid that is both ketogenic and glucogenic as it can be oxidized to produce alanine and acetyl-CoA. The ring structure can also be used to synthesize niacin, reducing the dietary requirement for this vitamin. Tryptophan metabolism to serotonin (and subsequently melatonin) requires BH4. Deficiencies here can lead to imbalances in these neurotransmitters (figure 4.3).","{'dee0215c-7152-4c97-afbd-f0d03484af84': 'Tryptophan is an essential amino acid that is both ketogenic and glucogenic as it can be oxidized to produce alanine and acetyl-CoA. The ring structure can also be used to synthesize niacin, reducing the dietary requirement for this vitamin. Tryptophan metabolism to serotonin (and subsequently melatonin) requires BH4. Deficiencies here can lead to imbalances in these neurotransmitters (figure 4.3).'}"
|
4 |
+
Figure 4.4,neuroscience/images/Figure 4.4.jpg,Figure 4.4: Glutamate metabolism as it interfaces with nitrogen transport and synthesis of GABA.,"Glutamate plays many key roles in amino acid metabolism and provides substrates for GABA and glutathione synthesis (figure 4.4). Additionally, glutamate plays a role in nitrogen movement within the body. Glutamate can be deaminated by glutamate dehydrogenase to yield α-ketoglutarate. This can enter directly into the TCA cycle or be transaminated (figure 4.4). Additionally, glutamate can be used to fix or free ammonium to generate glutamine—one of the essential, nontoxic carriers of ammonia.","{'62b26cb1-b780-486e-acbc-37dd751b58e7': 'Glutamate plays many key roles in amino acid metabolism and provides substrates for GABA and glutathione synthesis (figure 4.4). Additionally, glutamate plays a role in nitrogen movement within the body. Glutamate can be deaminated by glutamate dehydrogenase to yield α-ketoglutarate. This can enter directly into the TCA cycle or be transaminated (figure 4.4). Additionally, glutamate can be used to fix or free ammonium to generate glutamine—one of the essential, nontoxic carriers of ammonia.', '24801513-7b21-42ef-bf30-32be372bb1f6': 'Glutamate is the most important transmitter for normal brain function. Nearly all excitatory neurons in the central nervous system (CNS) are glutamatergic. Glutamate is a nonessential amino acid that does not cross the blood-brain barrier and therefore must be synthesized in neurons from local precursors. The most prevalent precursor for glutamate synthesis is glutamine, which is taken up into presynaptic terminals by the system A transporter 2 (SAT2) and is then metabolized to glutamate by the mitochondrial enzyme glutaminase (figure 2.3).', '29ebc630-cef4-4261-8494-6ed21b0f0016': 'Glutamate synthesized in the presynaptic cytoplasm is packaged into synaptic vesicles by vesicular glutamate transporters (VGLUTs). Once released, glutamate is removed from the synaptic cleft by the excitatory amino acid transporters (EAATs). EAATs are a family of five different Na+-dependent glutamate cotransporters. Some EAATs are present in glial cells and others in presynaptic terminals. Glutamate transported into glial cells via EAATs is converted into glutamine by the enzyme glutamine synthetase. Glutamine is then transported out of the glial cells by a different transporter, the system N transporter 1 (SN1), and transported into nerve terminals via SAT2. This overall sequence of events is referred to as the glutamate–glutamine cycle. This cycle allows glial cells and presynaptic terminals to cooperate both to maintain an adequate supply of glutamate for synaptic transmission and to rapidly terminate postsynaptic glutamate action (figure 2.4).'}"
|
5 |
+
Figure 4.6,neuroscience/images/Figure 4.6.jpg,Figure 4.6: Metabolism of methionine. Remethylation and transsulfuration of homocysteine are illustrated. Cofactor or enzymatic deficiencies can result in an elevation of homocysteine.,"Initially, methionine will condense with ATP to form SAM. SAM has a charged methyl group, which can be transferred to many different acceptor molecules; this step is considered irreversible as the amount of energy released is substantial. SAM is used by many biological pathways to donate methyl groups, and it is in consistent demand. After SAM loses its methyl group, the resulting compound, S-adenosylhomocysteine (SAH), is hydrolyzed to homocysteine and adenosine. Homocysteine, generated from this reaction, can either be remethylated in a reaction using both folate and cobalamin to resynthesize methionine or can be used for the synthesis of cysteine (figure 4.6).","{'ae28d1c5-0c2c-4e59-8391-fb88e7d08cb7': 'Methionine is an essential amino acid with a complex metabolism of clinical importance. Its metabolism interfaces with the folate cycle, cobalamin remethylation, and the synthesis of S-adenosylmethionine (SAM). Enzymatic or cofactor deficiencies can result in elevated homocysteine levels (hyperhomocysteinemia), which can have negative impacts systemically. Methionine, required for the synthesis of SAM, can be obtained from the diet or produced from remethylation of homocysteine using vitamin B12.', '95d35415-03a3-49ae-b442-2827f8f346a1': 'Initially, methionine will condense with ATP to form SAM. SAM has a charged methyl group, which can be transferred to many different acceptor molecules; this step is considered irreversible as the amount of energy released is substantial. SAM is used by many biological pathways to donate methyl groups, and it is in consistent demand. After SAM loses its methyl group, the resulting compound, S-adenosylhomocysteine (SAH), is hydrolyzed to homocysteine and adenosine. Homocysteine, generated from this reaction, can either be remethylated in a reaction using both folate and cobalamin to resynthesize methionine or can be used for the synthesis of cysteine (figure 4.6).', '663b595a-3866-4c1a-8f45-92381705bd10': 'Further metabolism of homocysteine provides the sulfur atom for the synthesis of cysteine. In this two-step process, homocysteine first reacts with serine to form cystathionine. This is followed by cleavage of cystathionine, which yields cysteine and α-ketobutyrate. The first reaction in this sequence, catalyzed by cystathionine β-synthase, is inhibited by cysteine. Thus, methionine, via homocysteine, is not used for cysteine synthesis unless the levels of cysteine in the body are lower than required for its metabolic functions. An adequate dietary supply of cysteine, therefore, can “spare” (or reduce) the dietary requirement for methionine (figure 4.6).'}"
|
6 |
+
Figure 4.6,neuroscience/images/Figure 4.6.jpg,Figure 4.6: Metabolism of methionine. Remethylation and transsulfuration of homocysteine are illustrated. Cofactor or enzymatic deficiencies can result in an elevation of homocysteine.,"Initially, methionine will condense with ATP to form SAM. SAM has a charged methyl group, which can be transferred to many different acceptor molecules; this step is considered irreversible as the amount of energy released is substantial. SAM is used by many biological pathways to donate methyl groups, and it is in consistent demand. After SAM loses its methyl group, the resulting compound, S-adenosylhomocysteine (SAH), is hydrolyzed to homocysteine and adenosine. Homocysteine, generated from this reaction, can either be remethylated in a reaction using both folate and cobalamin to resynthesize methionine or can be used for the synthesis of cysteine (figure 4.6).","{'ae28d1c5-0c2c-4e59-8391-fb88e7d08cb7': 'Methionine is an essential amino acid with a complex metabolism of clinical importance. Its metabolism interfaces with the folate cycle, cobalamin remethylation, and the synthesis of S-adenosylmethionine (SAM). Enzymatic or cofactor deficiencies can result in elevated homocysteine levels (hyperhomocysteinemia), which can have negative impacts systemically. Methionine, required for the synthesis of SAM, can be obtained from the diet or produced from remethylation of homocysteine using vitamin B12.', '95d35415-03a3-49ae-b442-2827f8f346a1': 'Initially, methionine will condense with ATP to form SAM. SAM has a charged methyl group, which can be transferred to many different acceptor molecules; this step is considered irreversible as the amount of energy released is substantial. SAM is used by many biological pathways to donate methyl groups, and it is in consistent demand. After SAM loses its methyl group, the resulting compound, S-adenosylhomocysteine (SAH), is hydrolyzed to homocysteine and adenosine. Homocysteine, generated from this reaction, can either be remethylated in a reaction using both folate and cobalamin to resynthesize methionine or can be used for the synthesis of cysteine (figure 4.6).', '663b595a-3866-4c1a-8f45-92381705bd10': 'Further metabolism of homocysteine provides the sulfur atom for the synthesis of cysteine. In this two-step process, homocysteine first reacts with serine to form cystathionine. This is followed by cleavage of cystathionine, which yields cysteine and α-ketobutyrate. The first reaction in this sequence, catalyzed by cystathionine β-synthase, is inhibited by cysteine. Thus, methionine, via homocysteine, is not used for cysteine synthesis unless the levels of cysteine in the body are lower than required for its metabolic functions. An adequate dietary supply of cysteine, therefore, can “spare” (or reduce) the dietary requirement for methionine (figure 4.6).'}"
|
7 |
+
Figure 2.1,neuroscience/images/Figure 2.1.jpg,Figure 2.1: Synthesis and degradation of acetylcholine.,"Acetylcholine (ACh) was the first identified neurotransmitter and is synthesized in nerve terminals from the precursors acetyl-CoA and choline, in a reaction catalyzed by choline acetyltransferase (ChAT) (figure 2.1). After synthesis in the cytoplasm of the neuron, a vesicular ACh transporter (VAChT) loads ACh into each cholinergic vesicle. The energy required to concentrate ACh within the vesicle is provided by the acidic pH of the vesicle lumen, which allows the VAChT to exchange H+ for ACh.","{'30504ceb-862e-48c1-bc39-4ebd97e7cd2a': 'Ferrier, D. R., ed. Lippincott Illustrated Reviews: Biochemistry, 7th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2017,\xa0 Chapter 20: Amino Acid Degradation and Synthesis, Chapter 21: Conversion of Amino Acids to Specialized Products.', 'f814fbb7-0506-470d-be91-332dc7f6e933': 'Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 37: Synthesis and Degradation of Amino Acids, Chapter 39: Tetrahydrofolate, Vitamin B12, and S-Adenosylmethionine.', '279012c4-5337-4f17-8e30-15c0a30fd0c7': 'Le, T., and V. Bhushan.\xa0First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 69, 83–85.', '1cb43208-8a51-4579-9c86-2ac4863a85bd': 'Peptide-secreting neurons generally synthesize polypeptides that are much larger than the final, “mature” peptide. Processing these polypeptides, which are called pre-propeptides, takes place within the neuron’s cell body by a sequence of reactions that occur in several intracellular organelles. Pre-propeptides are synthesized in the rough endoplasmic reticulum, where the signal sequence—that is, the sequence of amino acids indicating that the peptide is to be secreted—is removed. The remaining polypeptide,\xa0referred to as the propeptide, moves through the Golgi apparatus and is packaged into vesicles in the trans-Golgi network. The final stages of peptide neurotransmitter processing\xa0involve\xa0proteolytic cleavage and occur\xa0within the Golgi-associated vesicles.\xa0In addition to cleavage,\xa0modification of the ends of the peptide by glycosylation, phosphorylation, and disulfide bond formation is also common.', '43721d34-b597-459d-9a11-fed27bc8628c': 'Purves, D., G. J. Augustine, Dd. Fitzpatrick, L. C. Katz, A.-S. LaMantia, J. O. McNamara, and S. M. Williams, eds. Neuroscience, 2nd ed. Sunderland, MA: Sinauer Associates, 2001, Chapter 6: Neurotransmitters.', '474c3f8f-b2a3-4c5e-bac4-e6ab9d814896': 'Acetylcholine (ACh) was the first identified neurotransmitter and is synthesized in nerve terminals from the precursors acetyl-CoA\xa0and choline, in a reaction catalyzed by choline acetyltransferase (ChAT) (figure 2.1). After synthesis in the cytoplasm of the neuron, a vesicular ACh transporter (VAChT) loads ACh into each cholinergic vesicle. The energy required to concentrate ACh within the vesicle is provided by the acidic pH of the vesicle lumen, which allows the VAChT to exchange H+ for ACh.', '3ef1c28b-edf3-4c7d-8cfe-98104a3884de': '“Biochemistry of Nerve Transmission.” The Medical Biochemistry Page. http://themedicalbiochemistrypage.or…-transmission/.', '5f067d1d-a9fe-42d5-ba5d-00d875139d3a': '“Neurotransmitters and Receptors: Different Classes of Neurotransmitters, and Different Types of Receptors They Bind To.” Khan Academy. https://www.khanacademy.org/science/…heir-receptors.', '54b79b2a-82e4-4d60-8931-2b5fd438204d': 'As a brief review, glucose is taken up by the brain in an insulin-independent manner. The brain oxidizes glucose under most conditions with the exception of starvation states. Once the glucose is phosphorylated to glucose 6-phosphate (by hexokinase), it has three potential fates (figure 1.1):', '0babe716-7b82-4f49-b785-4b7efcc7d5d3': 'What is unique to the brain\xa0is that not all cell types\xa0oxidize glucose to the same extent, but\xa0there is a tight coupling that exists between cell types to support both energy demand and glutamate-mediated neurotransmission. This compartmentalized, coupled metabolism between neurons and astrocytes\xa0is essential for ATP production, neuronal excitability, and adaptations to stress.', '3657c3ea-7aa2-4b93-85f4-ab8eca86a4d2': 'In the context of this chapter, oxidative metabolism refers to the oxidation of a substrate (glucose) through mitochondrial metabolism versus\xa0glycolytic metabolism, which refers to the oxidation of glucose to lactate.', '3582281d-f4e1-4294-88e1-0f77fae600ed': 'To support the high energy demands imposed on neurons, they sustain a high rate of oxidative metabolism for ATP production compared to astrocytes. Despite this high rate of mitochondrial metabolism, glucose uptake is reduced when compared to astrocytes, in part due to the use of lactate as an energy source. Neurons show a preference for lactate over glucose when both substrates are present. There are several reasons why sustaining a low glycolytic rate but high oxidative rate is preferred in this tissue:', '977f700d-dda5-42c2-ab14-a789271e1739': 'To accommodate these two processes, neurons preferentially utilize lactate, which can be readily converted to pyruvate and enter the mitochondria (figure 1.2). The lactate required for neuronal metabolism is produced by astrocytic glucose oxidation and is discussed below.', 'cd766723-9078-4cfe-a5af-7e26de693949': 'Bélanger, M., I. Allaman, and P. J. Magistretti. “Brain Energy Metabolism: Focus on Astrocyte–Neuron Metabolic Cooperation.” Cell Metabolism 14, no. 6 (December 2011): 724–738, https://doi.org/10.1016/j.cmet.2011.08.016.', '7fd59828-b121-4cf5-9bf5-3e7779c2360c': 'Le, T., and V. Bhushan.\xa0First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 87, 314–315.', 'c3528409-5aee-410f-81f0-443b61264194': 'Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 46: Metabolism of the Nervous System.', '66a8b8c3-3424-4336-9832-393bb4d42d51': 'Magistretti, P. J., and I. Allaman. “A Cellular Perspective on Brain Energy Metabolism and Functional Imaging.” Neuron 86, no. 4 (May 2015): 883–901, https://doi.org/10.1016/j.neuron.2015.03.035.', 'daac396d-a353-40f3-a508-88eaa6a86b43': 'In contrast to most other small-molecule neurotransmitters, the postsynaptic actions of ACh are not terminated by reuptake but hydrolysis by acetylcholinesterase (AChE). This enzyme is concentrated in the synaptic cleft, ensuring a rapid decrease in ACh concentration after its release from the presynaptic terminal. The hydrolysis results in acetate and choline (figure 2.1), which is recycled by being transported back into nerve terminals, where it is used to resynthesize ACh. Organophosphates are one class of drugs known to interact with ACh signal transmission through the inhibition of AChE, allowing ACh to accumulate at cholinergic synapses. This buildup of ACh depolarizes the postsynaptic muscle cell and renders it refractory to subsequent ACh release, causing neuromuscular paralysis.'}"
|
8 |
+
Figure 2.1,neuroscience/images/Figure 2.1.jpg,Figure 2.1: Synthesis and degradation of acetylcholine.,"Acetylcholine (ACh) was the first identified neurotransmitter and is synthesized in nerve terminals from the precursors acetyl-CoA and choline, in a reaction catalyzed by choline acetyltransferase (ChAT) (figure 2.1). After synthesis in the cytoplasm of the neuron, a vesicular ACh transporter (VAChT) loads ACh into each cholinergic vesicle. The energy required to concentrate ACh within the vesicle is provided by the acidic pH of the vesicle lumen, which allows the VAChT to exchange H+ for ACh.","{'30504ceb-862e-48c1-bc39-4ebd97e7cd2a': 'Ferrier, D. R., ed. Lippincott Illustrated Reviews: Biochemistry, 7th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2017,\xa0 Chapter 20: Amino Acid Degradation and Synthesis, Chapter 21: Conversion of Amino Acids to Specialized Products.', 'f814fbb7-0506-470d-be91-332dc7f6e933': 'Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 37: Synthesis and Degradation of Amino Acids, Chapter 39: Tetrahydrofolate, Vitamin B12, and S-Adenosylmethionine.', '279012c4-5337-4f17-8e30-15c0a30fd0c7': 'Le, T., and V. Bhushan.\xa0First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 69, 83–85.', '1cb43208-8a51-4579-9c86-2ac4863a85bd': 'Peptide-secreting neurons generally synthesize polypeptides that are much larger than the final, “mature” peptide. Processing these polypeptides, which are called pre-propeptides, takes place within the neuron’s cell body by a sequence of reactions that occur in several intracellular organelles. Pre-propeptides are synthesized in the rough endoplasmic reticulum, where the signal sequence—that is, the sequence of amino acids indicating that the peptide is to be secreted—is removed. The remaining polypeptide,\xa0referred to as the propeptide, moves through the Golgi apparatus and is packaged into vesicles in the trans-Golgi network. The final stages of peptide neurotransmitter processing\xa0involve\xa0proteolytic cleavage and occur\xa0within the Golgi-associated vesicles.\xa0In addition to cleavage,\xa0modification of the ends of the peptide by glycosylation, phosphorylation, and disulfide bond formation is also common.', '43721d34-b597-459d-9a11-fed27bc8628c': 'Purves, D., G. J. Augustine, Dd. Fitzpatrick, L. C. Katz, A.-S. LaMantia, J. O. McNamara, and S. M. Williams, eds. Neuroscience, 2nd ed. Sunderland, MA: Sinauer Associates, 2001, Chapter 6: Neurotransmitters.', '474c3f8f-b2a3-4c5e-bac4-e6ab9d814896': 'Acetylcholine (ACh) was the first identified neurotransmitter and is synthesized in nerve terminals from the precursors acetyl-CoA\xa0and choline, in a reaction catalyzed by choline acetyltransferase (ChAT) (figure 2.1). After synthesis in the cytoplasm of the neuron, a vesicular ACh transporter (VAChT) loads ACh into each cholinergic vesicle. The energy required to concentrate ACh within the vesicle is provided by the acidic pH of the vesicle lumen, which allows the VAChT to exchange H+ for ACh.', '3ef1c28b-edf3-4c7d-8cfe-98104a3884de': '“Biochemistry of Nerve Transmission.” The Medical Biochemistry Page. http://themedicalbiochemistrypage.or…-transmission/.', '5f067d1d-a9fe-42d5-ba5d-00d875139d3a': '“Neurotransmitters and Receptors: Different Classes of Neurotransmitters, and Different Types of Receptors They Bind To.” Khan Academy. https://www.khanacademy.org/science/…heir-receptors.', '54b79b2a-82e4-4d60-8931-2b5fd438204d': 'As a brief review, glucose is taken up by the brain in an insulin-independent manner. The brain oxidizes glucose under most conditions with the exception of starvation states. Once the glucose is phosphorylated to glucose 6-phosphate (by hexokinase), it has three potential fates (figure 1.1):', '0babe716-7b82-4f49-b785-4b7efcc7d5d3': 'What is unique to the brain\xa0is that not all cell types\xa0oxidize glucose to the same extent, but\xa0there is a tight coupling that exists between cell types to support both energy demand and glutamate-mediated neurotransmission. This compartmentalized, coupled metabolism between neurons and astrocytes\xa0is essential for ATP production, neuronal excitability, and adaptations to stress.', '3657c3ea-7aa2-4b93-85f4-ab8eca86a4d2': 'In the context of this chapter, oxidative metabolism refers to the oxidation of a substrate (glucose) through mitochondrial metabolism versus\xa0glycolytic metabolism, which refers to the oxidation of glucose to lactate.', '3582281d-f4e1-4294-88e1-0f77fae600ed': 'To support the high energy demands imposed on neurons, they sustain a high rate of oxidative metabolism for ATP production compared to astrocytes. Despite this high rate of mitochondrial metabolism, glucose uptake is reduced when compared to astrocytes, in part due to the use of lactate as an energy source. Neurons show a preference for lactate over glucose when both substrates are present. There are several reasons why sustaining a low glycolytic rate but high oxidative rate is preferred in this tissue:', '977f700d-dda5-42c2-ab14-a789271e1739': 'To accommodate these two processes, neurons preferentially utilize lactate, which can be readily converted to pyruvate and enter the mitochondria (figure 1.2). The lactate required for neuronal metabolism is produced by astrocytic glucose oxidation and is discussed below.', 'cd766723-9078-4cfe-a5af-7e26de693949': 'Bélanger, M., I. Allaman, and P. J. Magistretti. “Brain Energy Metabolism: Focus on Astrocyte–Neuron Metabolic Cooperation.” Cell Metabolism 14, no. 6 (December 2011): 724–738, https://doi.org/10.1016/j.cmet.2011.08.016.', '7fd59828-b121-4cf5-9bf5-3e7779c2360c': 'Le, T., and V. Bhushan.\xa0First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 87, 314–315.', 'c3528409-5aee-410f-81f0-443b61264194': 'Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 46: Metabolism of the Nervous System.', '66a8b8c3-3424-4336-9832-393bb4d42d51': 'Magistretti, P. J., and I. Allaman. “A Cellular Perspective on Brain Energy Metabolism and Functional Imaging.” Neuron 86, no. 4 (May 2015): 883–901, https://doi.org/10.1016/j.neuron.2015.03.035.', 'daac396d-a353-40f3-a508-88eaa6a86b43': 'In contrast to most other small-molecule neurotransmitters, the postsynaptic actions of ACh are not terminated by reuptake but hydrolysis by acetylcholinesterase (AChE). This enzyme is concentrated in the synaptic cleft, ensuring a rapid decrease in ACh concentration after its release from the presynaptic terminal. The hydrolysis results in acetate and choline (figure 2.1), which is recycled by being transported back into nerve terminals, where it is used to resynthesize ACh. Organophosphates are one class of drugs known to interact with ACh signal transmission through the inhibition of AChE, allowing ACh to accumulate at cholinergic synapses. This buildup of ACh depolarizes the postsynaptic muscle cell and renders it refractory to subsequent ACh release, causing neuromuscular paralysis.'}"
|
9 |
+
Figure 2.2,neuroscience/images/Figure 2.2.jpg,Figure 2.2: ACh release and degradation. (A: acetyl-CoA; ACh: acetylcholine; AChE: acetylcholine esterase; Ch: choline; VAChT: vesicular ACh transporter),"A second class of ACh receptors are referred to as muscarinic ACh receptors (mAChRs). mAChRs are metabotropic and mediate most of the effects of ACh in the brain. Like other metabotropic receptors, mAChRs have seven helical membrane-spanning domains. Binding of ACh to the receptor causes a conformational change that permits G-proteins to bind to the cytoplasmic domain of the mAChR (figure 2.2).","{'b4795726-a834-453a-bfea-985baa8478e5': 'Many of the postsynaptic actions of ACh are mediated by the nicotinic ACh receptor (nAChR). nAChRs are nonselective cation channels that generate excitatory postsynaptic responses. Nicotinic receptors are large protein complexes consisting of five subunits. At the neuromuscular junction, the nAChR contains two α subunits, each of which has a binding site that binds a single molecule of ACh. Both ACh binding sites must be occupied for the receptor to be activated. In summary, the nAChR is a ligand-gated ion channel.', '538f2a7f-1632-46c2-8cb1-748638bca19a': 'A second class of ACh receptors are referred to as muscarinic ACh receptors (mAChRs). mAChRs are metabotropic and mediate most of the effects of ACh in the brain. Like other metabotropic receptors, mAChRs have seven helical membrane-spanning domains. Binding of ACh to the receptor causes a conformational change that permits G-proteins to bind to the cytoplasmic domain of the mAChR (figure 2.2).'}"
|
10 |
+
Figure 2.3,neuroscience/images/Figure 2.3.jpg,Figure 2.3: Glutamate and GABA synthesis. (α-KG: α-ketoglutarate; PLP: pyridoxal phosphate),"Glutamate is the most important transmitter for normal brain function. Nearly all excitatory neurons in the central nervous system (CNS) are glutamatergic. Glutamate is a nonessential amino acid that does not cross the blood-brain barrier and therefore must be synthesized in neurons from local precursors. The most prevalent precursor for glutamate synthesis is glutamine, which is taken up into presynaptic terminals by the system A transporter 2 (SAT2) and is then metabolized to glutamate by the mitochondrial enzyme glutaminase (figure 2.3).","{'62b26cb1-b780-486e-acbc-37dd751b58e7': 'Glutamate plays many key roles in amino acid metabolism and provides substrates for GABA and glutathione synthesis (figure 4.4). Additionally, glutamate plays a role in nitrogen movement within the body. Glutamate can be deaminated by glutamate dehydrogenase to yield α-ketoglutarate. This can enter directly into the TCA cycle or be transaminated (figure 4.4). Additionally, glutamate can be used to fix or free ammonium to generate glutamine—one of the essential, nontoxic carriers of ammonia.', '24801513-7b21-42ef-bf30-32be372bb1f6': 'Glutamate is the most important transmitter for normal brain function. Nearly all excitatory neurons in the central nervous system (CNS) are glutamatergic. Glutamate is a nonessential amino acid that does not cross the blood-brain barrier and therefore must be synthesized in neurons from local precursors. The most prevalent precursor for glutamate synthesis is glutamine, which is taken up into presynaptic terminals by the system A transporter 2 (SAT2) and is then metabolized to glutamate by the mitochondrial enzyme glutaminase (figure 2.3).', '29ebc630-cef4-4261-8494-6ed21b0f0016': 'Glutamate synthesized in the presynaptic cytoplasm is packaged into synaptic vesicles by vesicular glutamate transporters (VGLUTs). Once released, glutamate is removed from the synaptic cleft by the excitatory amino acid transporters (EAATs). EAATs are a family of five different Na+-dependent glutamate cotransporters. Some EAATs are present in glial cells and others in presynaptic terminals. Glutamate transported into glial cells via EAATs is converted into glutamine by the enzyme glutamine synthetase. Glutamine is then transported out of the glial cells by a different transporter, the system N transporter 1 (SN1), and transported into nerve terminals via SAT2. This overall sequence of events is referred to as the glutamate–glutamine cycle. This cycle allows glial cells and presynaptic terminals to cooperate both to maintain an adequate supply of glutamate for synaptic transmission and to rapidly terminate postsynaptic glutamate action (figure 2.4).', '466eee53-4364-44de-87f8-c625fdb6645f': 'Most inhibitory synapses in the brain and spinal cord use either γ-aminobutyric acid (GABA) or glycine as neurotransmitters. The predominant precursor for GABA synthesis is glucose, which is metabolized to glutamate by the tricarboxylic acid cycle enzymes (figure 2.3). The enzyme glutamic acid decarboxylase (GAD), which is found almost exclusively in GABAergic neurons, catalyzes the conversion of glutamate to GABA. GAD requires pyridoxal phosphate for activity; a deficiency of this vitamin can lead to diminished GABA synthesis.', '0d07f0a5-5274-46d6-a874-1e7b049c9f4f': 'Once GABA is synthesized, it is transported into synaptic vesicles via a vesicular inhibitory amino acid transporter (VIAAT). The mechanism of GABA removal is similar to that of glutamate. Both neurons and glia contain high-affinity Na+-dependent cotransporters for GABA, and these cotransporters are termed GATs. Most GABA is eventually converted to succinate, which is metabolized further in the tricarboxylic acid cycle that mediates cellular ATP synthesis.', '390b60b9-a56a-4cd8-ab99-9d8ee6bf9d47': 'Two mitochondrial enzymes are required for this degradation: GABA transaminase and succinic semialdehyde dehydrogenase.'}"
|
11 |
+
Figure 2.4,neuroscience/images/Figure 2.4.jpg,Figure 2.4: Glutamate release and reuptake. (EAAT: excitatory amino acid transporters),"Glutamate synthesized in the presynaptic cytoplasm is packaged into synaptic vesicles by vesicular glutamate transporters (VGLUTs). Once released, glutamate is removed from the synaptic cleft by the excitatory amino acid transporters (EAATs). EAATs are a family of five different Na+-dependent glutamate cotransporters. Some EAATs are present in glial cells and others in presynaptic terminals. Glutamate transported into glial cells via EAATs is converted into glutamine by the enzyme glutamine synthetase. Glutamine is then transported out of the glial cells by a different transporter, the system N transporter 1 (SN1), and transported into nerve terminals via SAT2. This overall sequence of events is referred to as the glutamate–glutamine cycle. This cycle allows glial cells and presynaptic terminals to cooperate both to maintain an adequate supply of glutamate for synaptic transmission and to rapidly terminate postsynaptic glutamate action (figure 2.4).","{'62b26cb1-b780-486e-acbc-37dd751b58e7': 'Glutamate plays many key roles in amino acid metabolism and provides substrates for GABA and glutathione synthesis (figure 4.4). Additionally, glutamate plays a role in nitrogen movement within the body. Glutamate can be deaminated by glutamate dehydrogenase to yield α-ketoglutarate. This can enter directly into the TCA cycle or be transaminated (figure 4.4). Additionally, glutamate can be used to fix or free ammonium to generate glutamine—one of the essential, nontoxic carriers of ammonia.', '24801513-7b21-42ef-bf30-32be372bb1f6': 'Glutamate is the most important transmitter for normal brain function. Nearly all excitatory neurons in the central nervous system (CNS) are glutamatergic. Glutamate is a nonessential amino acid that does not cross the blood-brain barrier and therefore must be synthesized in neurons from local precursors. The most prevalent precursor for glutamate synthesis is glutamine, which is taken up into presynaptic terminals by the system A transporter 2 (SAT2) and is then metabolized to glutamate by the mitochondrial enzyme glutaminase (figure 2.3).', '29ebc630-cef4-4261-8494-6ed21b0f0016': 'Glutamate synthesized in the presynaptic cytoplasm is packaged into synaptic vesicles by vesicular glutamate transporters (VGLUTs). Once released, glutamate is removed from the synaptic cleft by the excitatory amino acid transporters (EAATs). EAATs are a family of five different Na+-dependent glutamate cotransporters. Some EAATs are present in glial cells and others in presynaptic terminals. Glutamate transported into glial cells via EAATs is converted into glutamine by the enzyme glutamine synthetase. Glutamine is then transported out of the glial cells by a different transporter, the system N transporter 1 (SN1), and transported into nerve terminals via SAT2. This overall sequence of events is referred to as the glutamate–glutamine cycle. This cycle allows glial cells and presynaptic terminals to cooperate both to maintain an adequate supply of glutamate for synaptic transmission and to rapidly terminate postsynaptic glutamate action (figure 2.4).'}"
|
12 |
+
Figure 2.3,neuroscience/images/Figure 2.3.jpg,Figure 2.3: Glutamate and GABA synthesis. (α-KG: α-ketoglutarate; PLP: pyridoxal phosphate),"Glutamate is the most important transmitter for normal brain function. Nearly all excitatory neurons in the central nervous system (CNS) are glutamatergic. Glutamate is a nonessential amino acid that does not cross the blood-brain barrier and therefore must be synthesized in neurons from local precursors. The most prevalent precursor for glutamate synthesis is glutamine, which is taken up into presynaptic terminals by the system A transporter 2 (SAT2) and is then metabolized to glutamate by the mitochondrial enzyme glutaminase (figure 2.3).","{'62b26cb1-b780-486e-acbc-37dd751b58e7': 'Glutamate plays many key roles in amino acid metabolism and provides substrates for GABA and glutathione synthesis (figure 4.4). Additionally, glutamate plays a role in nitrogen movement within the body. Glutamate can be deaminated by glutamate dehydrogenase to yield α-ketoglutarate. This can enter directly into the TCA cycle or be transaminated (figure 4.4). Additionally, glutamate can be used to fix or free ammonium to generate glutamine—one of the essential, nontoxic carriers of ammonia.', '24801513-7b21-42ef-bf30-32be372bb1f6': 'Glutamate is the most important transmitter for normal brain function. Nearly all excitatory neurons in the central nervous system (CNS) are glutamatergic. Glutamate is a nonessential amino acid that does not cross the blood-brain barrier and therefore must be synthesized in neurons from local precursors. The most prevalent precursor for glutamate synthesis is glutamine, which is taken up into presynaptic terminals by the system A transporter 2 (SAT2) and is then metabolized to glutamate by the mitochondrial enzyme glutaminase (figure 2.3).', '29ebc630-cef4-4261-8494-6ed21b0f0016': 'Glutamate synthesized in the presynaptic cytoplasm is packaged into synaptic vesicles by vesicular glutamate transporters (VGLUTs). Once released, glutamate is removed from the synaptic cleft by the excitatory amino acid transporters (EAATs). EAATs are a family of five different Na+-dependent glutamate cotransporters. Some EAATs are present in glial cells and others in presynaptic terminals. Glutamate transported into glial cells via EAATs is converted into glutamine by the enzyme glutamine synthetase. Glutamine is then transported out of the glial cells by a different transporter, the system N transporter 1 (SN1), and transported into nerve terminals via SAT2. This overall sequence of events is referred to as the glutamate–glutamine cycle. This cycle allows glial cells and presynaptic terminals to cooperate both to maintain an adequate supply of glutamate for synaptic transmission and to rapidly terminate postsynaptic glutamate action (figure 2.4).', '466eee53-4364-44de-87f8-c625fdb6645f': 'Most inhibitory synapses in the brain and spinal cord use either γ-aminobutyric acid (GABA) or glycine as neurotransmitters. The predominant precursor for GABA synthesis is glucose, which is metabolized to glutamate by the tricarboxylic acid cycle enzymes (figure 2.3). The enzyme glutamic acid decarboxylase (GAD), which is found almost exclusively in GABAergic neurons, catalyzes the conversion of glutamate to GABA. GAD requires pyridoxal phosphate for activity; a deficiency of this vitamin can lead to diminished GABA synthesis.', '0d07f0a5-5274-46d6-a874-1e7b049c9f4f': 'Once GABA is synthesized, it is transported into synaptic vesicles via a vesicular inhibitory amino acid transporter (VIAAT). The mechanism of GABA removal is similar to that of glutamate. Both neurons and glia contain high-affinity Na+-dependent cotransporters for GABA, and these cotransporters are termed GATs. Most GABA is eventually converted to succinate, which is metabolized further in the tricarboxylic acid cycle that mediates cellular ATP synthesis.', '390b60b9-a56a-4cd8-ab99-9d8ee6bf9d47': 'Two mitochondrial enzymes are required for this degradation: GABA transaminase and succinic semialdehyde dehydrogenase.'}"
|
13 |
+
Figure 2.5,neuroscience/images/Figure 2.5.jpg,Figure 2.5: GABA and glycine release. (GAT: cotransporters for GABA; VIAAT: vesicular inhibitory amino acid transporter),The distribution of the neutral amino acid glycine in the CNS is more restricted than that of GABA. About half of the inhibitory synapses in the spinal cord use glycine; most other inhibitory synapses use GABA. Glycine is synthesized from serine by the mitochondrial isoform of serine hydroxymethyltransferase (figure 2.5) and is transported into synaptic vesicles via the same VIAAT that loads GABA into vesicles.,"{'ec1d3db9-6247-462a-aea3-c2d048bf6d68': 'Glycine is a key compound that functions as an essential substrate for various pathways, including the folate cycle, nucleotide synthesis, and synthesis of porphyrins (heme), glutathione, and creatine.', '4212e1fe-4eb0-4274-8994-9aaa32a0ac9e': 'The distribution of the neutral amino acid glycine in the CNS is more restricted than that of GABA. About half of the inhibitory synapses in the spinal cord use glycine; most other inhibitory synapses use GABA. Glycine is synthesized from serine by the mitochondrial isoform of serine hydroxymethyltransferase (figure 2.5) and is transported into synaptic vesicles via the same VIAAT that loads GABA into vesicles.', '229898ad-c1e5-4519-8ca6-64b198787192': 'Once released from the presynaptic cell, glycine is rapidly removed from the synaptic cleft by glycine transporters in the plasma membrane (figure 2.5).'}"
|
14 |
+
Figure 2.6,neuroscience/images/Figure 2.6.jpg,"Figure 2.6: Synthesis of dopamine, norepinephrine, and epinephrine.",The first step in catecholamine synthesis is catalyzed by tyrosine hydroxylase in a reaction requiring oxygen as a cosubstrate and tetrahydrobiopterin as a cofactor to synthesize dihydroxyphenylalanine (DOPA) (figure 2.6).,"{'1343fada-6249-4ba2-85b9-6d268bb14384': 'The first step in catecholamine synthesis is catalyzed by tyrosine hydroxylase in a reaction requiring oxygen as a cosubstrate and tetrahydrobiopterin as a cofactor to synthesize dihydroxyphenylalanine (DOPA) (figure 2.6).', '3df319ec-e98d-4f4e-9ad7-3a586e4ed1be': 'Dopamine is produced by the action of DOPA decarboxylase on DOPA. Following its synthesis in the cytoplasm of presynaptic terminals, dopamine is loaded into synaptic vesicles via a vesicular monoamine transporter (VMAT). Dopamine action in the synaptic cleft is terminated by reuptake of dopamine into nerve terminals or surrounding glial cells by a Na+-dependent dopamine cotransporter, termed DAT.', 'a38098f7-94bb-4ac9-a774-556ebf5eb182': 'The two major enzymes involved in the catabolism of dopamine are monoamine oxidase (MAO) and catechol O-methyltransferase (COMT). Both neurons and glia contain mitochondrial MAO and cytoplasmic COMT.', 'b51a4662-9d6c-42f2-83fc-8ad2d6beb3a9': 'Once released, dopamine acts exclusively by activating G-protein–coupled receptors. Most dopamine receptor subtypes act by either activating or inhibiting adenylyl cyclase. Activation of these receptors generally contributes to complex behaviors.', '8c9edc66-b93d-4f3e-9f1f-a979b14aa20d': 'Norepinephrine (also called noradrenaline) is used as a neurotransmitter and influences sleep and wakefulness, arousal, attention, and feeding behavior. Perhaps the most prominent noradrenergic neurons are sympathetic ganglion cells, which employ norepinephrine as the major peripheral transmitter in this division of the visceral motor system.', '4905d479-d447-48e6-91eb-1513a0b1325b': 'Norepinephrine synthesis requires dopamine β-hydroxylase, which catalyzes the production of norepinephrine from dopamine (figure 2.6). Norepinephrine is then loaded into synaptic vesicles via the same VMAT involved in vesicular dopamine transport.', 'e6fd5437-7024-4040-bbee-425be9e19a84': 'Norepinephrine is cleared from the synaptic cleft by the norepinephrine transporter (NET), an Na+-dependent cotransporter that is also capable of taking up dopamine. NET is a molecular target of amphetamine, which acts as a stimulant by producing a net increase in the release of norepinephrine and dopamine. Like dopamine, norepinephrine is degraded by MAO and COMT.', 'd1119468-0f78-46ff-94d8-79d9bf3202e0': 'Epinephrine (also called adrenaline) is found in the brain at lower levels than the other catecholamines and is also present in fewer brain neurons than other catecholamines. Epinephrine-secreting neurons regulate respiration and cardiac function. The enzyme that synthesizes epinephrine, phenylethanolamine-N-methyltransferase (figure 2.6), is present only in epinephrine-secreting neurons. Otherwise, the metabolism of epinephrine is very similar to that of norepinephrine. Epinephrine is loaded into vesicles via the VMAT. No plasma membrane transporter specific for epinephrine has been identified, although the NET is capable of transporting epinephrine. As already noted, epinephrine acts on both α- and β-adrenergic receptors.'}"
|
15 |
+
Figure 2.6,neuroscience/images/Figure 2.6.jpg,"Figure 2.6: Synthesis of dopamine, norepinephrine, and epinephrine.",The first step in catecholamine synthesis is catalyzed by tyrosine hydroxylase in a reaction requiring oxygen as a cosubstrate and tetrahydrobiopterin as a cofactor to synthesize dihydroxyphenylalanine (DOPA) (figure 2.6).,"{'1343fada-6249-4ba2-85b9-6d268bb14384': 'The first step in catecholamine synthesis is catalyzed by tyrosine hydroxylase in a reaction requiring oxygen as a cosubstrate and tetrahydrobiopterin as a cofactor to synthesize dihydroxyphenylalanine (DOPA) (figure 2.6).', '3df319ec-e98d-4f4e-9ad7-3a586e4ed1be': 'Dopamine is produced by the action of DOPA decarboxylase on DOPA. Following its synthesis in the cytoplasm of presynaptic terminals, dopamine is loaded into synaptic vesicles via a vesicular monoamine transporter (VMAT). Dopamine action in the synaptic cleft is terminated by reuptake of dopamine into nerve terminals or surrounding glial cells by a Na+-dependent dopamine cotransporter, termed DAT.', 'a38098f7-94bb-4ac9-a774-556ebf5eb182': 'The two major enzymes involved in the catabolism of dopamine are monoamine oxidase (MAO) and catechol O-methyltransferase (COMT). Both neurons and glia contain mitochondrial MAO and cytoplasmic COMT.', 'b51a4662-9d6c-42f2-83fc-8ad2d6beb3a9': 'Once released, dopamine acts exclusively by activating G-protein–coupled receptors. Most dopamine receptor subtypes act by either activating or inhibiting adenylyl cyclase. Activation of these receptors generally contributes to complex behaviors.', '8c9edc66-b93d-4f3e-9f1f-a979b14aa20d': 'Norepinephrine (also called noradrenaline) is used as a neurotransmitter and influences sleep and wakefulness, arousal, attention, and feeding behavior. Perhaps the most prominent noradrenergic neurons are sympathetic ganglion cells, which employ norepinephrine as the major peripheral transmitter in this division of the visceral motor system.', '4905d479-d447-48e6-91eb-1513a0b1325b': 'Norepinephrine synthesis requires dopamine β-hydroxylase, which catalyzes the production of norepinephrine from dopamine (figure 2.6). Norepinephrine is then loaded into synaptic vesicles via the same VMAT involved in vesicular dopamine transport.', 'e6fd5437-7024-4040-bbee-425be9e19a84': 'Norepinephrine is cleared from the synaptic cleft by the norepinephrine transporter (NET), an Na+-dependent cotransporter that is also capable of taking up dopamine. NET is a molecular target of amphetamine, which acts as a stimulant by producing a net increase in the release of norepinephrine and dopamine. Like dopamine, norepinephrine is degraded by MAO and COMT.', 'd1119468-0f78-46ff-94d8-79d9bf3202e0': 'Epinephrine (also called adrenaline) is found in the brain at lower levels than the other catecholamines and is also present in fewer brain neurons than other catecholamines. Epinephrine-secreting neurons regulate respiration and cardiac function. The enzyme that synthesizes epinephrine, phenylethanolamine-N-methyltransferase (figure 2.6), is present only in epinephrine-secreting neurons. Otherwise, the metabolism of epinephrine is very similar to that of norepinephrine. Epinephrine is loaded into vesicles via the VMAT. No plasma membrane transporter specific for epinephrine has been identified, although the NET is capable of transporting epinephrine. As already noted, epinephrine acts on both α- and β-adrenergic receptors.'}"
|
16 |
+
Figure 2.7,neuroscience/images/Figure 2.7.jpg,Figure 2.7: Histamine synthesis.,Histamine is produced from the amino acid histidine by a histidine decarboxylase (figure 2.7) and is transported into vesicles via the same VMAT as the catecholamines. No plasma membrane histamine transporter has been identified yet.,"{'57619371-622c-42a4-b61d-b66dd30f7e78': 'Histamine is found in neurons in the hypothalamus that send sparse but widespread projections to almost all regions of the brain and spinal cord. The central histamine projections mediate arousal and attention, similar to central ACh and norepinephrine projections. Histamine also controls the reactivity of the vestibular system. Allergic reactions or tissue damage cause release of histamine from mast cells in the bloodstream. The close proximity of mast cells to blood vessels, together with the potent actions of histamine on blood vessels, raises the possibility that histamine may influence brain blood flow.', '9cdc0fc7-1e2a-42cc-a225-35628c099e68': 'Histamine is produced from the amino acid histidine by a histidine decarboxylase (figure 2.7) and is transported into vesicles via the same VMAT as the catecholamines. No plasma membrane histamine transporter has been identified yet.', '4a5380aa-826d-4eb9-93be-8100dc1c8b53': 'Histamine is degraded by the combined actions of histamine methyltransferase and MAO.'}"
|
17 |
+
Figure 2.8,neuroscience/images/Figure 2.8.jpg,Figure 2.8: Histamine release and reuptake. (ALDH: aldehyde dehydrogenase; DAO: diamine oxidase; HA: histamine; HNMT: N-methyltransferase; IA: imidazole acetaldehyde; IAA: imidazoleacetic acid; IAAR: imidazoleacetic acid riboside; NMH: N-methylhistamine; N-MIA: methylimidazole acetaldehyde; N-MIAA: N-methylimidazoleacetic acetic acid; OC3: organic cation transporter 3; PMAT: plasma membrane monoamine transporter),"The four known types of histamine receptors are all metabotropic receptors. Of the four, only two of the receptors (H1 and H2) are well characterized. Because of the role of histamine receptors in mediating allergic responses, many histamine receptor antagonists have been developed as antihistamine agents. Antihistamines that cross the blood-brain barrier, such as diphenhydramine (Benadryl), act as sedatives by interfering with the roles of histamine in CNS arousal. Antagonists of the H1 receptor also are used to prevent motion sickness, perhaps because of the role of histamine in controlling vestibular function (figure 2.8).","{'3367e478-afe0-4f1b-b8fe-c437ce6a7ba8': 'The four known types of histamine receptors are all metabotropic receptors.\xa0 Of the four, only two of the receptors (H1 and H2) are well characterized.\xa0\xa0Because of the role of histamine receptors in mediating allergic responses, many histamine receptor antagonists have been developed as antihistamine agents. Antihistamines that cross the blood-brain barrier, such as diphenhydramine (Benadryl), act as sedatives by interfering with the roles of histamine in CNS arousal. Antagonists of the H1 receptor also are used to prevent motion sickness, perhaps because of the role of histamine in controlling vestibular function (figure 2.8).', '21cfb848-a6ba-4241-b66b-0f28a292c8ca': 'H2 receptors control the secretion of gastric acid in the digestive system, allowing H2 receptor antagonists to be used in treating a variety of upper gastrointestinal disorders (e.g., peptic ulcers).'}"
|
18 |
+
Figure 2.9,neuroscience/images/Figure 2.9.jpg,Figure 2.9: Serotonin synthesis.,"Serotonin, or 5-hydroxytryptamine (5-HT), was initially thought to increase vascular tone by virtue of its presence in blood serum (hence the name serotonin). 5-HT is synthesized from the amino acid tryptophan, which is an essential dietary requirement. Tryptophan is taken up into neurons by a plasma membrane transporter and hydroxylated in a reaction catalyzed by the enzyme tryptophan-5-hydroxylase (figure 2.9), the rate-limiting step for 5-HT synthesis. Loading of 5-HT into synaptic vesicles is done by the VMAT that is also responsible for loading other monoamines into synaptic vesicles. The synaptic effects of serotonin are terminated by transport back into nerve terminals via a specific serotonin transporter (SERT) that is present in the presynaptic plasma membrane and is encoded by the 5HTT gene. Many antidepressant drugs are selective serotonin reuptake inhibitors (SSRIs) that inhibit transport of 5-HT by SERT. Perhaps the best-known example of an SSRI is the antidepressant drug Prozac.","{'049c88f5-7e1b-4bcb-9c36-5156c17a5560': 'Serotonin, or 5-hydroxytryptamine (5-HT), was initially thought to increase vascular tone by virtue of its presence in blood serum (hence the name serotonin). 5-HT is synthesized from the amino acid tryptophan, which is an essential dietary requirement. Tryptophan is taken up into neurons by a plasma membrane transporter and hydroxylated in a reaction catalyzed by the enzyme tryptophan-5-hydroxylase (figure 2.9), the rate-limiting step for 5-HT synthesis. Loading of 5-HT into synaptic vesicles is done by the VMAT that is also responsible for loading other monoamines into synaptic vesicles. The synaptic effects of serotonin are terminated by transport back into nerve terminals via a specific serotonin transporter (SERT) that is present in the presynaptic plasma membrane and is encoded by the 5HTT gene. Many antidepressant drugs are selective serotonin reuptake inhibitors (SSRIs) that inhibit transport of 5-HT by SERT. Perhaps the best-known example of an SSRI is the antidepressant drug Prozac.'}"
|
19 |
+
Figure 1.1,neuroscience/images/Figure 1.1.jpg,"Figure 1.1: Potential fates of glucose oxidation. i. Glucose is oxidized to lactate; ii. Glucose is oxidized through the pentose phosphate pathway (PPP); iii. Glucose is stored as glycogen, which only occurs in astrocytes; iv. Pyruvate can be oxidized through the mitochondria but is not a primary fate. (GLUTs: glucose transporters; MCTs: monocarboxylate transporters; TCA: tricarboxylic acid; DHAP: dihydroxyacetone phosphate; GA3P: glyceraldehyde 3-phosphate)","As a brief review, glucose is taken up by the brain in an insulin-independent manner. The brain oxidizes glucose under most conditions with the exception of starvation states. Once the glucose is phosphorylated to glucose 6-phosphate (by hexokinase), it has three potential fates (figure 1.1):","{'30504ceb-862e-48c1-bc39-4ebd97e7cd2a': 'Ferrier, D. R., ed. Lippincott Illustrated Reviews: Biochemistry, 7th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2017,\xa0 Chapter 20: Amino Acid Degradation and Synthesis, Chapter 21: Conversion of Amino Acids to Specialized Products.', 'f814fbb7-0506-470d-be91-332dc7f6e933': 'Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 37: Synthesis and Degradation of Amino Acids, Chapter 39: Tetrahydrofolate, Vitamin B12, and S-Adenosylmethionine.', '279012c4-5337-4f17-8e30-15c0a30fd0c7': 'Le, T., and V. Bhushan.\xa0First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 69, 83–85.', '1cb43208-8a51-4579-9c86-2ac4863a85bd': 'Peptide-secreting neurons generally synthesize polypeptides that are much larger than the final, “mature” peptide. Processing these polypeptides, which are called pre-propeptides, takes place within the neuron’s cell body by a sequence of reactions that occur in several intracellular organelles. Pre-propeptides are synthesized in the rough endoplasmic reticulum, where the signal sequence—that is, the sequence of amino acids indicating that the peptide is to be secreted—is removed. The remaining polypeptide,\xa0referred to as the propeptide, moves through the Golgi apparatus and is packaged into vesicles in the trans-Golgi network. The final stages of peptide neurotransmitter processing\xa0involve\xa0proteolytic cleavage and occur\xa0within the Golgi-associated vesicles.\xa0In addition to cleavage,\xa0modification of the ends of the peptide by glycosylation, phosphorylation, and disulfide bond formation is also common.', '43721d34-b597-459d-9a11-fed27bc8628c': 'Purves, D., G. J. Augustine, Dd. Fitzpatrick, L. C. Katz, A.-S. LaMantia, J. O. McNamara, and S. M. Williams, eds. Neuroscience, 2nd ed. Sunderland, MA: Sinauer Associates, 2001, Chapter 6: Neurotransmitters.', '474c3f8f-b2a3-4c5e-bac4-e6ab9d814896': 'Acetylcholine (ACh) was the first identified neurotransmitter and is synthesized in nerve terminals from the precursors acetyl-CoA\xa0and choline, in a reaction catalyzed by choline acetyltransferase (ChAT) (figure 2.1). After synthesis in the cytoplasm of the neuron, a vesicular ACh transporter (VAChT) loads ACh into each cholinergic vesicle. The energy required to concentrate ACh within the vesicle is provided by the acidic pH of the vesicle lumen, which allows the VAChT to exchange H+ for ACh.', '3ef1c28b-edf3-4c7d-8cfe-98104a3884de': '“Biochemistry of Nerve Transmission.” The Medical Biochemistry Page. http://themedicalbiochemistrypage.or…-transmission/.', '5f067d1d-a9fe-42d5-ba5d-00d875139d3a': '“Neurotransmitters and Receptors: Different Classes of Neurotransmitters, and Different Types of Receptors They Bind To.” Khan Academy. https://www.khanacademy.org/science/…heir-receptors.', '54b79b2a-82e4-4d60-8931-2b5fd438204d': 'As a brief review, glucose is taken up by the brain in an insulin-independent manner. The brain oxidizes glucose under most conditions with the exception of starvation states. Once the glucose is phosphorylated to glucose 6-phosphate (by hexokinase), it has three potential fates (figure 1.1):', '0babe716-7b82-4f49-b785-4b7efcc7d5d3': 'What is unique to the brain\xa0is that not all cell types\xa0oxidize glucose to the same extent, but\xa0there is a tight coupling that exists between cell types to support both energy demand and glutamate-mediated neurotransmission. This compartmentalized, coupled metabolism between neurons and astrocytes\xa0is essential for ATP production, neuronal excitability, and adaptations to stress.', '3657c3ea-7aa2-4b93-85f4-ab8eca86a4d2': 'In the context of this chapter, oxidative metabolism refers to the oxidation of a substrate (glucose) through mitochondrial metabolism versus\xa0glycolytic metabolism, which refers to the oxidation of glucose to lactate.', '3582281d-f4e1-4294-88e1-0f77fae600ed': 'To support the high energy demands imposed on neurons, they sustain a high rate of oxidative metabolism for ATP production compared to astrocytes. Despite this high rate of mitochondrial metabolism, glucose uptake is reduced when compared to astrocytes, in part due to the use of lactate as an energy source. Neurons show a preference for lactate over glucose when both substrates are present. There are several reasons why sustaining a low glycolytic rate but high oxidative rate is preferred in this tissue:', '977f700d-dda5-42c2-ab14-a789271e1739': 'To accommodate these two processes, neurons preferentially utilize lactate, which can be readily converted to pyruvate and enter the mitochondria (figure 1.2). The lactate required for neuronal metabolism is produced by astrocytic glucose oxidation and is discussed below.', 'cd766723-9078-4cfe-a5af-7e26de693949': 'Bélanger, M., I. Allaman, and P. J. Magistretti. “Brain Energy Metabolism: Focus on Astrocyte–Neuron Metabolic Cooperation.” Cell Metabolism 14, no. 6 (December 2011): 724–738, https://doi.org/10.1016/j.cmet.2011.08.016.', '7fd59828-b121-4cf5-9bf5-3e7779c2360c': 'Le, T., and V. Bhushan.\xa0First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 87, 314–315.', 'c3528409-5aee-410f-81f0-443b61264194': 'Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 46: Metabolism of the Nervous System.', '66a8b8c3-3424-4336-9832-393bb4d42d51': 'Magistretti, P. J., and I. Allaman. “A Cellular Perspective on Brain Energy Metabolism and Functional Imaging.” Neuron 86, no. 4 (May 2015): 883–901, https://doi.org/10.1016/j.neuron.2015.03.035.'}"
|
20 |
+
Figure 1.2,neuroscience/images/Figure 1.2.jpg,Figure 1.2: Comparison of neuron and astrocyte metabolism. (PDH: pyruvate dehydrogenase complex; PKM1/2: pyruvate kinase isoforms M1 and M2; TCA: tricarboxylic acid; DHAP: dihydroxyacetone phosphate; GA3P: glyceraldehyde 3-phosphate),"To accommodate these two processes, neurons preferentially utilize lactate, which can be readily converted to pyruvate and enter the mitochondria (figure 1.2). The lactate required for neuronal metabolism is produced by astrocytic glucose oxidation and is discussed below.","{'30504ceb-862e-48c1-bc39-4ebd97e7cd2a': 'Ferrier, D. R., ed. Lippincott Illustrated Reviews: Biochemistry, 7th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2017,\xa0 Chapter 20: Amino Acid Degradation and Synthesis, Chapter 21: Conversion of Amino Acids to Specialized Products.', 'f814fbb7-0506-470d-be91-332dc7f6e933': 'Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 37: Synthesis and Degradation of Amino Acids, Chapter 39: Tetrahydrofolate, Vitamin B12, and S-Adenosylmethionine.', '279012c4-5337-4f17-8e30-15c0a30fd0c7': 'Le, T., and V. Bhushan.\xa0First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 69, 83–85.', '1cb43208-8a51-4579-9c86-2ac4863a85bd': 'Peptide-secreting neurons generally synthesize polypeptides that are much larger than the final, “mature” peptide. Processing these polypeptides, which are called pre-propeptides, takes place within the neuron’s cell body by a sequence of reactions that occur in several intracellular organelles. Pre-propeptides are synthesized in the rough endoplasmic reticulum, where the signal sequence—that is, the sequence of amino acids indicating that the peptide is to be secreted—is removed. The remaining polypeptide,\xa0referred to as the propeptide, moves through the Golgi apparatus and is packaged into vesicles in the trans-Golgi network. The final stages of peptide neurotransmitter processing\xa0involve\xa0proteolytic cleavage and occur\xa0within the Golgi-associated vesicles.\xa0In addition to cleavage,\xa0modification of the ends of the peptide by glycosylation, phosphorylation, and disulfide bond formation is also common.', '43721d34-b597-459d-9a11-fed27bc8628c': 'Purves, D., G. J. Augustine, Dd. Fitzpatrick, L. C. Katz, A.-S. LaMantia, J. O. McNamara, and S. M. Williams, eds. Neuroscience, 2nd ed. Sunderland, MA: Sinauer Associates, 2001, Chapter 6: Neurotransmitters.', '474c3f8f-b2a3-4c5e-bac4-e6ab9d814896': 'Acetylcholine (ACh) was the first identified neurotransmitter and is synthesized in nerve terminals from the precursors acetyl-CoA\xa0and choline, in a reaction catalyzed by choline acetyltransferase (ChAT) (figure 2.1). After synthesis in the cytoplasm of the neuron, a vesicular ACh transporter (VAChT) loads ACh into each cholinergic vesicle. The energy required to concentrate ACh within the vesicle is provided by the acidic pH of the vesicle lumen, which allows the VAChT to exchange H+ for ACh.', '3ef1c28b-edf3-4c7d-8cfe-98104a3884de': '“Biochemistry of Nerve Transmission.” The Medical Biochemistry Page. http://themedicalbiochemistrypage.or…-transmission/.', '5f067d1d-a9fe-42d5-ba5d-00d875139d3a': '“Neurotransmitters and Receptors: Different Classes of Neurotransmitters, and Different Types of Receptors They Bind To.” Khan Academy. https://www.khanacademy.org/science/…heir-receptors.', '54b79b2a-82e4-4d60-8931-2b5fd438204d': 'As a brief review, glucose is taken up by the brain in an insulin-independent manner. The brain oxidizes glucose under most conditions with the exception of starvation states. Once the glucose is phosphorylated to glucose 6-phosphate (by hexokinase), it has three potential fates (figure 1.1):', '0babe716-7b82-4f49-b785-4b7efcc7d5d3': 'What is unique to the brain\xa0is that not all cell types\xa0oxidize glucose to the same extent, but\xa0there is a tight coupling that exists between cell types to support both energy demand and glutamate-mediated neurotransmission. This compartmentalized, coupled metabolism between neurons and astrocytes\xa0is essential for ATP production, neuronal excitability, and adaptations to stress.', '3657c3ea-7aa2-4b93-85f4-ab8eca86a4d2': 'In the context of this chapter, oxidative metabolism refers to the oxidation of a substrate (glucose) through mitochondrial metabolism versus\xa0glycolytic metabolism, which refers to the oxidation of glucose to lactate.', '3582281d-f4e1-4294-88e1-0f77fae600ed': 'To support the high energy demands imposed on neurons, they sustain a high rate of oxidative metabolism for ATP production compared to astrocytes. Despite this high rate of mitochondrial metabolism, glucose uptake is reduced when compared to astrocytes, in part due to the use of lactate as an energy source. Neurons show a preference for lactate over glucose when both substrates are present. There are several reasons why sustaining a low glycolytic rate but high oxidative rate is preferred in this tissue:', '977f700d-dda5-42c2-ab14-a789271e1739': 'To accommodate these two processes, neurons preferentially utilize lactate, which can be readily converted to pyruvate and enter the mitochondria (figure 1.2). The lactate required for neuronal metabolism is produced by astrocytic glucose oxidation and is discussed below.', 'cd766723-9078-4cfe-a5af-7e26de693949': 'Bélanger, M., I. Allaman, and P. J. Magistretti. “Brain Energy Metabolism: Focus on Astrocyte–Neuron Metabolic Cooperation.” Cell Metabolism 14, no. 6 (December 2011): 724–738, https://doi.org/10.1016/j.cmet.2011.08.016.', '7fd59828-b121-4cf5-9bf5-3e7779c2360c': 'Le, T., and V. Bhushan.\xa0First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 87, 314–315.', 'c3528409-5aee-410f-81f0-443b61264194': 'Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 46: Metabolism of the Nervous System.', '66a8b8c3-3424-4336-9832-393bb4d42d51': 'Magistretti, P. J., and I. Allaman. “A Cellular Perspective on Brain Energy Metabolism and Functional Imaging.” Neuron 86, no. 4 (May 2015): 883–901, https://doi.org/10.1016/j.neuron.2015.03.035.'}"
|
21 |
+
Figure 1.3,neuroscience/images/Figure 1.3.jpg,Figure 1.3: Lactate and glutamate shuttling between the astrocyte and the neuron. (GS: glutamine synthetase; GLS: glutaminase; LDH: lactate dehydrogenase; EAATs: excitatory amino acid transporters; MCT: monocarboxylate transporter; GluR: glutamate receptor).,"Astrocytes recycle glutamate through sodium-dependent high-affinity glutamate transporters. Following glutamate uptake, astrocytes also play an important role in transferring this neurotransmitter back to neurons. This transfer is achieved by a process called the glutamate-glutamine cycle, which involves both glutamine synthetase (GS) and glutaminase (GLS) (figure 1.3).","{'15462cd8-bb7b-4a5a-b88e-0cf73680cdfe': 'To terminate synaptic transmission and maintain neuronal excitability, astrocytes play a key role in the rapid removal of neurotransmitters from the synaptic cleft. The removal of glutamate is specifically critical as this is the primary excitatory neurotransmitter, and overstimulation of glutamate receptors is highly toxic to neurons.', '79ed036b-ba19-4089-bbda-6b6be86a03a6': 'Astrocytes recycle glutamate through sodium-dependent high-affinity glutamate transporters. Following glutamate uptake, astrocytes also play an important role in transferring this neurotransmitter back to neurons. This transfer is achieved by a process called the glutamate-glutamine cycle,\xa0which involves both glutamine synthetase (GS) and glutaminase (GLS) (figure 1.3).', 'adec9f56-e2ea-4bc0-8908-d927475ca190': 'Finally, lactate can be used as an energy substrate for neurons for oxidative-derived ATP production (figure 1.3).'}"
|
22 |
+
Figure 1.3,neuroscience/images/Figure 1.3.jpg,Figure 1.3: Lactate and glutamate shuttling between the astrocyte and the neuron. (GS: glutamine synthetase; GLS: glutaminase; LDH: lactate dehydrogenase; EAATs: excitatory amino acid transporters; MCT: monocarboxylate transporter; GluR: glutamate receptor).,"Astrocytes recycle glutamate through sodium-dependent high-affinity glutamate transporters. Following glutamate uptake, astrocytes also play an important role in transferring this neurotransmitter back to neurons. This transfer is achieved by a process called the glutamate-glutamine cycle, which involves both glutamine synthetase (GS) and glutaminase (GLS) (figure 1.3).","{'15462cd8-bb7b-4a5a-b88e-0cf73680cdfe': 'To terminate synaptic transmission and maintain neuronal excitability, astrocytes play a key role in the rapid removal of neurotransmitters from the synaptic cleft. The removal of glutamate is specifically critical as this is the primary excitatory neurotransmitter, and overstimulation of glutamate receptors is highly toxic to neurons.', '79ed036b-ba19-4089-bbda-6b6be86a03a6': 'Astrocytes recycle glutamate through sodium-dependent high-affinity glutamate transporters. Following glutamate uptake, astrocytes also play an important role in transferring this neurotransmitter back to neurons. This transfer is achieved by a process called the glutamate-glutamine cycle,\xa0which involves both glutamine synthetase (GS) and glutaminase (GLS) (figure 1.3).', 'adec9f56-e2ea-4bc0-8908-d927475ca190': 'Finally, lactate can be used as an energy substrate for neurons for oxidative-derived ATP production (figure 1.3).'}"
|
neuroscience/corpus.csv
ADDED
@@ -0,0 +1,174 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
unique_id,web-scraper-start-url,sub_chapters_x,sub_chapters-href,paragraph,is_paragraph,sub_section_headings,fig_num,sub_chapters_y,images-src,image_caption
|
2 |
+
6bf44020-483d-40e8-8b07-35931c186991,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Pyridoxal phosphate (B6 or PLP),False,Pyridoxal phosphate (B6 or PLP),,,,
|
3 |
+
58acae5d-5ff6-4790-a048-40ab59cbf5a1,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,All transamination reactions require PLP as a cofactor. These reactions are essential for moving (or donating) ammonia from an amino acid to a keto-acid to generate a different amino acid.,True,Pyridoxal phosphate (B6 or PLP),,,,
|
4 |
+
c41262ae-dedf-4313-bb08-a6409fb135a5,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Tetrahydrobiopterin (BH4),False,Tetrahydrobiopterin (BH4),,,,
|
5 |
+
08cb2569-24b2-49ec-a81d-63c6df7d97f7,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"BH4 is a cofactor synthesized from GTP. It is oxidized during hydroxylation reactions, most notably the conversion of phenylalanine to tyrosine. Enzymatic deficiencies leading to decreased synthesis of BH4 can present similar to deficiencies in phenylalanine metabolism.",True,Tetrahydrobiopterin (BH4),,,,
|
6 |
+
62532b3d-06dd-4e9c-bad1-18ea81670399,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Tetrahydrofolate (FH4),False,Tetrahydrofolate (FH4),,,,
|
7 |
+
600b763c-582e-439a-ab5c-950c0a8fa282,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Folate can exist in many forms and is often referred to as tetrahydrofolate. FH4 is often found in various forms with a one-carbon group attached. These one-carbon groups, which make up the one-carbon pool, can be oxidized or reduced. One-carbon groups can be transferred to other compounds and play essential roles in the synthesis of glycine from serine, the synthesis of the base thymine (required for DNA synthesis), the purine bases required for both DNA and RNA synthesis, and the transfer of methyl groups to vitamin B12.",True,Tetrahydrofolate (FH4),,,,
|
8 |
+
52fce476-efca-434f-b914-019aa1726125,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Synthesis of specialized products,False,Synthesis of specialized products,,,,
|
9 |
+
7be14b02-11d5-40f4-a101-21e3b2e43b66,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,The following highlights some of the key aspects of amino acid metabolism.,True,Synthesis of specialized products,,,,
|
10 |
+
2b619524-64a0-4412-93bf-1aa6b7e23113,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Phenylalanine and tyrosine,False,Phenylalanine and tyrosine,,,,
|
11 |
+
78effb87-80dd-42a6-940d-801ba33f16f9,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Phenylalanine (Phe) is an essential amino acid, and hydroxylation of Phe by phenylalanine hydroxylase (PAH) generates tyrosine (figure 4.1). This conversion requires BH4, and deficiencies in either the cofactor or the enzyme PAH can result in phenylketonuria. Additionally, the inability to synthesize tyrosine will make this a conditionally essential amino acid and potentially negatively impact the synthesis of downstream compounds illustrated in figure 4.2.",True,Phenylalanine and tyrosine,Figure 4.1,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.1.png,Figure 4.1: Metabolism of phenylalanine requires BH4 and also produces tyrosine. Deficiencies in cofactor or phenylalanine hydroxylase can result in phenylketonuria.
|
12 |
+
6778e5ab-6768-4fae-86c7-ee2b6de8164c,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Tyrosine can be produced from phenylalanine metabolism and is required for the production of melanin and the catecholamines. Deficiencies can occur at several different locations in the pathway and result in albinism (tyrosinase), alkaptonuria (homogentisate oxidase), or tyrosinemia, which can manifest due to deficiencies in several enzymes along the pathway (figure 4.1).",True,Phenylalanine and tyrosine,Figure 4.1,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.1.png,Figure 4.1: Metabolism of phenylalanine requires BH4 and also produces tyrosine. Deficiencies in cofactor or phenylalanine hydroxylase can result in phenylketonuria.
|
13 |
+
b0403b1e-657b-4d4b-98d8-8678d08dbdcb,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Phenylketonuria,False,Phenylketonuria,,,,
|
14 |
+
18777451-f3c2-47cd-bbec-de130a32c81d,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Phenylketonuria (PKU) is one of the more common amino acid metabolic disorders and is inherited in an autosomal recessive fashion. There are no symptoms of untreated phenylketonuria in the first months of life. Therefore newborn screening is essential for diagnosis and initiation of treatment, which prevents the devastating effects of infantile hyperphenylalaninemia. The screening method detects elevated titers of the amino acid phenylalanine in the blood. A positive test result (Phe greater than 150 μmol/L) prompts the physician to begin a phenylalanine-restricted formula and requires a confirmatory quantitative Phe level.",True,Phenylketonuria,,,,
|
15 |
+
c7aa5f15-d71c-4885-a90b-a5e33465f0f6,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Glycine,False,Glycine,,,,
|
16 |
+
ec1d3db9-6247-462a-aea3-c2d048bf6d68,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Glycine is a key compound that functions as an essential substrate for various pathways, including the folate cycle, nucleotide synthesis, and synthesis of porphyrins (heme), glutathione, and creatine.",True,Glycine,,,,
|
17 |
+
29572eb1-3a0e-4ccb-9eb5-e9015cc7b581,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Arginine,False,Arginine,,,,
|
18 |
+
4c5fab46-e1c2-4267-9bea-16a040fcfe50,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Arginine is a nonessential amino acid as it can be produced in the urea cycle. Deficiencies in the urea cycle can cause arginine to become conditionally essential. In these cases, management and supplementation are needed.",True,Arginine,,,,
|
19 |
+
4bffc503-a72c-4258-89f6-b7e5db4a7882,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Tryptophan,False,Tryptophan,,,,
|
20 |
+
dee0215c-7152-4c97-afbd-f0d03484af84,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Tryptophan is an essential amino acid that is both ketogenic and glucogenic as it can be oxidized to produce alanine and acetyl-CoA. The ring structure can also be used to synthesize niacin, reducing the dietary requirement for this vitamin. Tryptophan metabolism to serotonin (and subsequently melatonin) requires BH4. Deficiencies here can lead to imbalances in these neurotransmitters (figure 4.3).",True,Tryptophan,Figure 4.3,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.3.png,Figure 4.3: Metabolism of tryptophan to melatonin.
|
21 |
+
f178b212-e09b-46d1-ab4c-a54f345278ff,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Glutamate,False,Glutamate,,,,
|
22 |
+
62b26cb1-b780-486e-acbc-37dd751b58e7,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Glutamate plays many key roles in amino acid metabolism and provides substrates for GABA and glutathione synthesis (figure 4.4). Additionally, glutamate plays a role in nitrogen movement within the body. Glutamate can be deaminated by glutamate dehydrogenase to yield α-ketoglutarate. This can enter directly into the TCA cycle or be transaminated (figure 4.4). Additionally, glutamate can be used to fix or free ammonium to generate glutamine—one of the essential, nontoxic carriers of ammonia.",True,Glutamate,Figure 4.4,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.4.png,Figure 4.4: Glutamate metabolism as it interfaces with nitrogen transport and synthesis of GABA.
|
23 |
+
9f5e41f1-bb1d-4158-810d-c9ec2864a09f,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Isoleucine, leucine, and valine (branched-chain amino acids)",False,"Isoleucine, leucine, and valine (branched-chain amino acids)",,,,
|
24 |
+
72de8aa2-1bd4-4e86-b83f-b1859f761573,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Oxidation of isoleucine, leucine, and valine, collectively described as branched-chain amino acids, occurs in all tissues and is a key fuel source for skeletal muscle. As these amino acids are approximately 25 percent of the amino acid pool, they provide both energy and available substrate to replenish the TCA cycle. The initial step in their metabolism, like all amino acids, is the transamination to generate a keto-acid. These compounds then undergo oxidative decarboxylation by a multiunit enzyme similar to the pyruvate dehydrogenase complex with similar cofactor requirements, and the remaining carbons can enter the TCA cycle.",True,"Isoleucine, leucine, and valine (branched-chain amino acids)",,,,
|
25 |
+
29966792-0cc9-4e38-8e0a-69651b48ac98,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Maple syrup urine disease,False,Maple syrup urine disease,,,,
|
26 |
+
6cf9e8b5-2267-4339-a19d-18fbdacaad2d,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Deficiencies in the metabolism of branched-chain amino acids can result in the diagnosis of maple syrup urine disease (MSUD). With an incidence of 1 in 100,000, MSUD is rare even among the inborn errors of metabolism. However, the distinct sweet odor of the patient’s urine, similar to that of maple syrup, distinguishes this condition as one of the more recognizable metabolic disorders. It is caused by deficient oxidative decarboxylation of α-keto acid metabolites of isoleucine, leucine, and valine. Affected infants can become symptomatic during the first days of life, with poor feeding, lethargy, seizures, and occasionally coma. Milder forms of MSUD may present later in life, with developmental delays and intellectual disability. Maple syrup urine disease is primarily treated by diet but also by avoiding circumstances that increase catabolism, such as high fever and dehydration. If a metabolic crisis occurs, emergency treatment in a hospital is necessary to stabilize the patient.",True,Maple syrup urine disease,,,,
|
27 |
+
916c6c09-60fc-4a2a-a1c1-c22a1bac3b41,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Methionine,False,Methionine,,,,
|
28 |
+
ae28d1c5-0c2c-4e59-8391-fb88e7d08cb7,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Methionine is an essential amino acid with a complex metabolism of clinical importance. Its metabolism interfaces with the folate cycle, cobalamin remethylation, and the synthesis of S-adenosylmethionine (SAM). Enzymatic or cofactor deficiencies can result in elevated homocysteine levels (hyperhomocysteinemia), which can have negative impacts systemically. Methionine, required for the synthesis of SAM, can be obtained from the diet or produced from remethylation of homocysteine using vitamin B12.",True,Methionine,,,,
|
29 |
+
95d35415-03a3-49ae-b442-2827f8f346a1,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Initially, methionine will condense with ATP to form SAM. SAM has a charged methyl group, which can be transferred to many different acceptor molecules; this step is considered irreversible as the amount of energy released is substantial. SAM is used by many biological pathways to donate methyl groups, and it is in consistent demand. After SAM loses its methyl group, the resulting compound, S-adenosylhomocysteine (SAH), is hydrolyzed to homocysteine and adenosine. Homocysteine, generated from this reaction, can either be remethylated in a reaction using both folate and cobalamin to resynthesize methionine or can be used for the synthesis of cysteine (figure 4.6).",True,Methionine,Figure 4.6,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.6-1.png,Figure 4.6: Metabolism of methionine. Remethylation and transsulfuration of homocysteine are illustrated. Cofactor or enzymatic deficiencies can result in an elevation of homocysteine.
|
30 |
+
1f9e4220-6ed5-4b8c-bdfe-bf3796048568,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Remethylation of homocysteine,False,Remethylation of homocysteine,,,,
|
31 |
+
e2827154-f257-4025-902c-59b768a51eae,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Homocysteine can be converted back into methionine by using both methyl-FH4 and vitamin B12. This is the only reaction in which methyl-FH4 can donate the methyl group. In this reaction, the methyl group from FH4 is transferred to cobalamin associated with homocysteine methyltransferase. Homocysteine receives the methyl group from this charged cobalamin cofactor, and methionine is regenerated. If homocysteine methyltransferase is defective, or if vitamin B12 or FH4 levels are insufficient, homocysteine will accumulate. Elevated homocysteine levels have been linked to cardiovascular and neurologic diseases. A consequence of vitamin B12 deficiency is the accumulation of methyl-FH4 and a decrease in other folate derivatives. This is known as the methyl-trap hypothesis; because of the B12 deficiency, most of the carbons in the FH4 pool are trapped in the methyl-FH4 form, which is the most stable. The carbons cannot be released from the folate because the one reaction in which they participate cannot occur due to the B12 deficiency. This leads to a functional folate deficiency, even though total levels of folate are normal.",True,Remethylation of homocysteine,,,,
|
32 |
+
d9daa817-9325-413c-b48a-91d7acaa3407,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"A folate deficiency (whether functional or actual) leads to megaloblastic anemia caused by an inability of blood cell precursors to synthesize DNA and, therefore, to divide. This leads to large, partially replicated cells being released into the blood to attempt to replenish the cells that have died. Folate deficiencies also have been linked to an increased incidence of neural tube defects, such as spina bifida, in mothers who become pregnant while folate deficient.",True,Remethylation of homocysteine,,,,
|
33 |
+
daf88d9f-8854-4d59-8bc9-cdf287a9ad9d,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Transsulfuration pathway,False,Transsulfuration pathway,,,,
|
34 |
+
663b595a-3866-4c1a-8f45-92381705bd10,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Further metabolism of homocysteine provides the sulfur atom for the synthesis of cysteine. In this two-step process, homocysteine first reacts with serine to form cystathionine. This is followed by cleavage of cystathionine, which yields cysteine and α-ketobutyrate. The first reaction in this sequence, catalyzed by cystathionine β-synthase, is inhibited by cysteine. Thus, methionine, via homocysteine, is not used for cysteine synthesis unless the levels of cysteine in the body are lower than required for its metabolic functions. An adequate dietary supply of cysteine, therefore, can “spare” (or reduce) the dietary requirement for methionine (figure 4.6).",True,Transsulfuration pathway,Figure 4.6,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.6-1.png,Figure 4.6: Metabolism of methionine. Remethylation and transsulfuration of homocysteine are illustrated. Cofactor or enzymatic deficiencies can result in an elevation of homocysteine.
|
35 |
+
3f8887c4-ad03-4dab-881b-f3da78925232,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,Consequences of elevated homocysteine,False,Consequences of elevated homocysteine,,,,
|
36 |
+
e79e5d00-4d28-4d28-b116-e3a279314b10,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Homocysteine levels can accumulate in several ways, which are related to both folic acid and vitamin B12 metabolism. As SAM is constantly being used as a methyl donor, this results in consistent production of SAH. Consequently, this leads to the constant production of homocysteine. The homocysteine produced can be either remethylated to methionine or condensed with serine to form cystathionine. The major pathway of homocysteine metabolism is remethylation by N 5-methyl-FH4, which requires vitamin B12. The liver also contains a second pathway in which betaine (a degradation product of choline) can donate a methyl group to homocysteine to form methionine, but this is a minor pathway. The conversion of homocysteine to cystathionine requires pyridoxal phosphate (PLP). Thus, if an individual is deficient in vitamin B12, the conversion of homocysteine to methionine by the major route is inhibited. This directs homocysteine to produce cystathionine, which eventually produces cysteine. Homocysteine also accumulates in the blood if a mutation is present in the enzyme that converts N 5,N10-methylene-FH4 to N 5-methyl-FH4. When this occurs, the levels of N 5-methyl-FH4 are too low to allow homocysteine to be converted to methionine. The loss of this pathway, coupled with the feedback inhibition by cysteine on cystathionine formation, also leads to elevated homocysteine levels in the blood.",True,Consequences of elevated homocysteine,,,,
|
37 |
+
22d55661-d2a1-4165-b77a-7f77f608b48b,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"A third way in which serum homocysteine levels can be elevated is by a mutated cystathionine β-synthase or a deficiency in vitamin B6, the required cofactor for that enzyme. These defects block the ability of homocysteine to be converted to cystathionine, and the homocysteine that does accumulate cannot all be accommodated by conversion to methionine. Thus, an accumulation of homocysteine results.",True,Consequences of elevated homocysteine,,,,
|
38 |
+
23ebbb8d-5df4-4b0a-8a86-4dcdc3f34e13,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,References and resources,False,References and resources,,,,
|
39 |
+
30504ceb-862e-48c1-bc39-4ebd97e7cd2a,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Ferrier, D. R., ed. Lippincott Illustrated Reviews: Biochemistry, 7th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2017, Chapter 20: Amino Acid Degradation and Synthesis, Chapter 21: Conversion of Amino Acids to Specialized Products.",True,References and resources,,,,
|
40 |
+
f814fbb7-0506-470d-be91-332dc7f6e933,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 37: Synthesis and Degradation of Amino Acids, Chapter 39: Tetrahydrofolate, Vitamin B12, and S-Adenosylmethionine.",True,References and resources,,,,
|
41 |
+
279012c4-5337-4f17-8e30-15c0a30fd0c7,https://pressbooks.lib.vt.edu/neuroscience/,4. Amino acid metabolism and specialized products,https://pressbooks.lib.vt.edu/neuroscience/chapter/amino-acid-metabolism-and-specialized-products/,"Le, T., and V. Bhushan. First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 69, 83–85.",True,References and resources,,,,
|
42 |
+
1cb43208-8a51-4579-9c86-2ac4863a85bd,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Peptide-secreting neurons generally synthesize polypeptides that are much larger than the final, “mature” peptide. Processing these polypeptides, which are called pre-propeptides, takes place within the neuron’s cell body by a sequence of reactions that occur in several intracellular organelles. Pre-propeptides are synthesized in the rough endoplasmic reticulum, where the signal sequence—that is, the sequence of amino acids indicating that the peptide is to be secreted—is removed. The remaining polypeptide, referred to as the propeptide, moves through the Golgi apparatus and is packaged into vesicles in the trans-Golgi network. The final stages of peptide neurotransmitter processing involve proteolytic cleavage and occur within the Golgi-associated vesicles. In addition to cleavage, modification of the ends of the peptide by glycosylation, phosphorylation, and disulfide bond formation is also common.",True,References and resources,,,,
|
43 |
+
74ff5c0f-f1de-482c-a9a0-87a1567cc968,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,propeptides,False,propeptides,,,,
|
44 |
+
d9bf6917-597e-4d24-a558-f50524f4d2a3,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,propeptide,False,propeptide,,,,
|
45 |
+
11787a3d-2d77-437f-82c7-6c680d40f24b,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Neuropeptides often are coreleased with small-molecule neurotransmitters. Thus, peptidergic synapses often elicit complex postsynaptic responses. Following release, these neuropeptides are inactivated into amino acid fragments by enzymes called peptidases that are typically located on the extracellular surface of the plasma membrane.",True,propeptide,,,,
|
46 |
+
32ed08a5-a9bb-49f3-8795-ca59adfc0f45,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"The biological activity of the peptide neurotransmitters depends on their amino acid sequence. Based on their sequences, neuropeptide transmitters have been loosely grouped into five categories:",True,propeptide,,,,
|
47 |
+
ce1c467c-868b-4c62-9798-907ea92ff8d6,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,Substance P is an eleven-amino-acid peptide classified as a brain/gut peptide due to its expression in both the human hippocampus and neocortex and gastrointestinal tract. It is also released from C fibers—afferents in peripheral nerves that convey information about pain and temperature.,True,propeptide,,,,
|
48 |
+
7f1184b2-47d7-4faa-add5-a543142e715c,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Substance P is a sensory neurotransmitter in the spinal cord, where its release can be inhibited by opioid peptides released from spinal cord interneurons, resulting in the suppression of pain.",True,propeptide,,,,
|
49 |
+
1c9da8d5-dbb7-4360-b1d3-5aa569138c02,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Opioid peptides were initially discovered in the 1970s while screening for endorphins, or endogenous compounds that mimicked the actions of morphine. The endogenous ligands of the opioid receptors have been identified and fall into three classes: endorphins, enkephalins, and dynorphins.",True,propeptide,,,,
|
50 |
+
fff38297-13d7-489b-8dab-7edbef0aae48,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,Each ligand is synthesized in an inactive pre-propeptide derived from distinct genes. Opioid precursor processing is tissue-specific and carried out within the Golgi apparatus.,True,propeptide,,,,
|
51 |
+
f767fa78-ad70-4cae-a74f-fe4e3be75121,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Opioid peptides are often colocalized with neurotransmitters, such as GABA and 5-HT, and are found widely distributed in many regions of the brain. In general, opioids tend to be depressants. Opioids are also involved in more complex behaviors such as sexual attraction and aggressive and submissive behaviors. They have also been implicated in psychiatric disorders such as schizophrenia and autism, although the evidence for this is debated. Repeated administration of opioids can lead to tolerance, addiction, or dependence; therefore therapeutic use is highly regulated. There are three well-characterized opioid receptor subtypes (μ, δ, and κ) that play a role in reward mechanisms as well as addiction.",True,propeptide,,,,
|
52 |
+
a3390ac0-8706-403a-a8e9-5635004f1301,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,Neuropeptide receptors,False,Neuropeptide receptors,,,,
|
53 |
+
aa602229-93eb-4cee-8294-5b006e47d93e,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Virtually all neuropeptides initiate their effects by activating G-protein–coupled receptors, however, studying these metabotropic peptide receptors in the brain has been difficult as there are few known specific agonists and antagonists. Neuropeptide receptor activation is important for a variety of homeostatic responses such as regulating the postganglionic output from sympathetic ganglia and the activity of the gut. Other peptide receptors, such as the neuropeptide Y receptor, are also involved in the initiation and maintenance of feeding behaviors that can lead to satiety or obesity, depending on regulation. Additional behaviors attributed to activation of peptide receptors include anxiety and panic attacks. These responses can be addressed through the use of antagonists of cholecystokinin receptors.",True,Neuropeptide receptors,,,,
|
54 |
+
1278d6da-b2cf-483a-9c2b-38193a0b0db6,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,Unconventional neurotransmitters,False,Unconventional neurotransmitters,,,,
|
55 |
+
e743f99f-78d5-4156-bdcc-8f77c9a15662,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"There are also some unusual molecules that are used for signaling between neurons and their targets. These chemical signals can be considered as neurotransmitters because of their roles in interneuronal signaling and because their release from neurons is regulated by Ca2+. However, they are unconventional in comparison with other neurotransmitters because:",True,Unconventional neurotransmitters,,,,
|
56 |
+
3bb6cd79-4a64-48ea-8d71-4caa0b9c99a0,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Endocannabinoids are a family of related endogenous signals that interact with cannabinoid receptors. These receptors are the molecular targets of Δ9-tetrahydrocannabinol, the psychoactive component of the marijuana plant.",True,Unconventional neurotransmitters,,,,
|
57 |
+
414ac167-de6c-47e7-8e9b-7d696872205a,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,Production of endocannabinoids is stimulated by:,False,Production of endocannabinoids is stimulated by:,,,,
|
58 |
+
63d92da0-8f09-4b33-8df2-478497ffe5e0,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"At least two types of cannabinoid receptors have been identified, with most actions of endocannabinoids in the CNS. The CB1 receptor is a G-protein–coupled receptor related to the metabotropic receptors for ACh, glutamate, and other conventional neurotransmitters.",True,Production of endocannabinoids is stimulated by:,,,,
|
59 |
+
f5ad11b5-443c-444c-bac5-c44a53c8a028,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Nitric oxide (NO) is an unusual and especially interesting chemical signal. It is a gas produced by the action of nitric oxide synthase, an enzyme that converts the amino acid arginine into a metabolite (citrulline) and simultaneously generates NO.",True,Production of endocannabinoids is stimulated by:,,,,
|
60 |
+
439486af-7a2b-4c4c-8518-0780baff41a1,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Within neurons, NO synthase is regulated by Ca2+ binding to the Ca2+ sensor protein calmodulin. Once produced, NO can permeate the plasma membrane and act inside nearby cells. Thus, this gaseous signal has a range of influence that extends well beyond the cell of origin. This property makes NO a potentially useful agent for coordinating the activities of multiple cells in a localized region and may mediate certain forms of synaptic plasticity that spread within small networks of neurons.",True,Production of endocannabinoids is stimulated by:,,,,
|
61 |
+
6688e789-ef93-471b-ac19-239cb6d003d0,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"All of the known actions of NO are mediated within its cellular targets; for this reason, NO often is considered a second messenger rather than a neurotransmitter. Some of the actions of NO are due to the activation of the enzyme guanylyl cyclase, which then produces the second messenger cGMP within target cells. Due to the gaseous nature of NO, termination of signal is difficult to characterize; NO will diffuse and the reduction in concentration is a likely termination.",True,Production of endocannabinoids is stimulated by:,,,,
|
62 |
+
2b46a5d8-f448-4d1b-9a10-a181f40d951e,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Carbon monoxide (CO) is generated in neurons by the enzymatic cleavage of heme by heme oxygenase-2. CO binds hemoglobin and binds enzymes within the electron transport chain, however, in the case of the neuron, it is part of the neurovascular coupling mechanism and increases local vasodilation.",True,Production of endocannabinoids is stimulated by:,,,,
|
63 |
+
cf53e3dc-312a-4101-af22-e75b9085d151,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,ATP and other purines,False,ATP and other purines,,,,
|
64 |
+
b034d821-e060-4b84-9c90-e132a6d13cc9,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"All synaptic vesicles contain ATP, which is coreleased with one or more “classical” neurotransmitters. It has been known since the 1920s that the extracellular application of ATP (or its breakdown products AMP and adenosine) can elicit electrical responses in neurons.",True,ATP and other purines,,,,
|
65 |
+
6f7b0fb9-fcae-4d50-b279-ed01952be351,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"ATP acts as an excitatory neurotransmitter in motor neurons of the spinal cord, as well as in sensory and autonomic ganglia. Extracellular enzymes degrade released ATP to adenosine, which has its own set of signaling actions. Thus, adenosine cannot be considered a classical neurotransmitter because it is not stored in synaptic vesicles or released in a Ca2+-dependent manner. Several enzymes are involved in the rapid catabolism and removal of purines from extracellular locations. Receptors for both ATP and adenosine are widely distributed in the nervous system as well as in many other tissues. There are three classes of these purinergic receptors. One class consists of ionotropic receptors called P2X receptors. The structure of these receptors is unique among ionotropic receptors because each subunit has a transmembrane domain that crosses the membrane only twice. The other two classes of purinergic receptors, P2Y, are G-protein–coupled metabotropic receptors. The two classes differ in their sensitivity to agonists—one type is preferentially stimulated by adenosine, whereas the other is preferentially activated by ATP.",True,ATP and other purines,,,,
|
66 |
+
d7d6cf19-589a-4252-8624-0ec808cd0955,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,References and resources,False,References and resources,,,,
|
67 |
+
43721d34-b597-459d-9a11-fed27bc8628c,https://pressbooks.lib.vt.edu/neuroscience/,3. Neuropeptides and unconventional neurotransmitters,https://pressbooks.lib.vt.edu/neuroscience/chapter/neuropeptides-and-unconventional-neurotransmitters/,"Purves, D., G. J. Augustine, Dd. Fitzpatrick, L. C. Katz, A.-S. LaMantia, J. O. McNamara, and S. M. Williams, eds. Neuroscience, 2nd ed. Sunderland, MA: Sinauer Associates, 2001, Chapter 6: Neurotransmitters.",True,References and resources,,,,
|
68 |
+
474c3f8f-b2a3-4c5e-bac4-e6ab9d814896,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Acetylcholine (ACh) was the first identified neurotransmitter and is synthesized in nerve terminals from the precursors acetyl-CoA and choline, in a reaction catalyzed by choline acetyltransferase (ChAT) (figure 2.1). After synthesis in the cytoplasm of the neuron, a vesicular ACh transporter (VAChT) loads ACh into each cholinergic vesicle. The energy required to concentrate ACh within the vesicle is provided by the acidic pH of the vesicle lumen, which allows the VAChT to exchange H+ for ACh.",True,References and resources,Figure 2.1,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.1.png,Figure 2.1: Synthesis and degradation of acetylcholine.
|
69 |
+
a8a6fc86-19e3-4f6e-bb7e-401738a5fa43,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,ChAT,False,ChAT,,,,
|
70 |
+
68d0a187-0aa4-45a7-9f9e-49174f1b3021,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,VAChT,False,VAChT,,,,
|
71 |
+
538d7fe9-a098-45d2-9332-44d3f8d1fd14,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Termination of signal,False,Termination of signal,,,,
|
72 |
+
daac396d-a353-40f3-a508-88eaa6a86b43,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"In contrast to most other small-molecule neurotransmitters, the postsynaptic actions of ACh are not terminated by reuptake but hydrolysis by acetylcholinesterase (AChE). This enzyme is concentrated in the synaptic cleft, ensuring a rapid decrease in ACh concentration after its release from the presynaptic terminal. The hydrolysis results in acetate and choline (figure 2.1), which is recycled by being transported back into nerve terminals, where it is used to resynthesize ACh. Organophosphates are one class of drugs known to interact with ACh signal transmission through the inhibition of AChE, allowing ACh to accumulate at cholinergic synapses. This buildup of ACh depolarizes the postsynaptic muscle cell and renders it refractory to subsequent ACh release, causing neuromuscular paralysis.",True,Termination of signal,Figure 2.1,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.1.png,Figure 2.1: Synthesis and degradation of acetylcholine.
|
73 |
+
a67fde95-cd32-4a58-aba6-72a33971b121,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Acetylcholine receptors,False,Acetylcholine receptors,,,,
|
74 |
+
b4795726-a834-453a-bfea-985baa8478e5,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Many of the postsynaptic actions of ACh are mediated by the nicotinic ACh receptor (nAChR). nAChRs are nonselective cation channels that generate excitatory postsynaptic responses. Nicotinic receptors are large protein complexes consisting of five subunits. At the neuromuscular junction, the nAChR contains two α subunits, each of which has a binding site that binds a single molecule of ACh. Both ACh binding sites must be occupied for the receptor to be activated. In summary, the nAChR is a ligand-gated ion channel.",True,Acetylcholine receptors,,,,
|
75 |
+
538f2a7f-1632-46c2-8cb1-748638bca19a,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"A second class of ACh receptors are referred to as muscarinic ACh receptors (mAChRs). mAChRs are metabotropic and mediate most of the effects of ACh in the brain. Like other metabotropic receptors, mAChRs have seven helical membrane-spanning domains. Binding of ACh to the receptor causes a conformational change that permits G-proteins to bind to the cytoplasmic domain of the mAChR (figure 2.2).",True,Acetylcholine receptors,Figure 2.2,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.2.png,Figure 2.2: ACh release and degradation. (A: acetyl-CoA; ACh: acetylcholine; AChE: acetylcholine esterase; Ch: choline; VAChT: vesicular ACh transporter)
|
76 |
+
73a3b896-9aba-4175-835b-6be3de5fc273,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Glutamate,False,Glutamate,,,,
|
77 |
+
24801513-7b21-42ef-bf30-32be372bb1f6,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Glutamate is the most important transmitter for normal brain function. Nearly all excitatory neurons in the central nervous system (CNS) are glutamatergic. Glutamate is a nonessential amino acid that does not cross the blood-brain barrier and therefore must be synthesized in neurons from local precursors. The most prevalent precursor for glutamate synthesis is glutamine, which is taken up into presynaptic terminals by the system A transporter 2 (SAT2) and is then metabolized to glutamate by the mitochondrial enzyme glutaminase (figure 2.3).",True,Glutamate,Figure 2.3,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.3.png,Figure 2.3: Glutamate and GABA synthesis. (α-KG: α-ketoglutarate; PLP: pyridoxal phosphate)
|
78 |
+
29ebc630-cef4-4261-8494-6ed21b0f0016,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Glutamate synthesized in the presynaptic cytoplasm is packaged into synaptic vesicles by vesicular glutamate transporters (VGLUTs). Once released, glutamate is removed from the synaptic cleft by the excitatory amino acid transporters (EAATs). EAATs are a family of five different Na+-dependent glutamate cotransporters. Some EAATs are present in glial cells and others in presynaptic terminals. Glutamate transported into glial cells via EAATs is converted into glutamine by the enzyme glutamine synthetase. Glutamine is then transported out of the glial cells by a different transporter, the system N transporter 1 (SN1), and transported into nerve terminals via SAT2. This overall sequence of events is referred to as the glutamate–glutamine cycle. This cycle allows glial cells and presynaptic terminals to cooperate both to maintain an adequate supply of glutamate for synaptic transmission and to rapidly terminate postsynaptic glutamate action (figure 2.4).",True,Glutamate,Figure 2.4,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.4.png,Figure 2.4: Glutamate release and reuptake. (EAAT: excitatory amino acid transporters)
|
79 |
+
244a1c9c-f094-4e8a-a6cc-b5b6d1a67d32,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Glutamate receptors,False,Glutamate receptors,,,,
|
80 |
+
9c138972-0ef7-40d3-8c21-75a56a3bd60e,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"There are several types of ionotropic glutamate receptors: AMPA receptors, NMDA receptors, and kainate receptors, named after the agonists that activate them: AMPA (α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate), NMDA (N-methyl-d-aspartate), and kainic acid. All of these receptors are glutamate-gated cation channels that allow the passage of Na+ and K+. Therefore AMPA, kainate, and NMDA receptor activation always produces excitatory postsynaptic responses. Most central excitatory synapses possess both AMPA and NMDA receptors. Antagonist drugs that selectively block either AMPA or NMDA receptors are often used to identify synaptic responses mediated by each receptor type. The physiological roles of kainate receptors are less well defined; in some cases, these receptors are found on presynaptic terminals and serve as a feedback mechanism to regulate glutamate release.",True,Glutamate receptors,,,,
|
81 |
+
e74b6ce1-9497-4918-9e9e-49ad285a6fd3,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"In addition to these ionotropic glutamate receptors, there are three classes of metabotropic glutamate receptors (mGluRs). These receptors differ in their coupling to intracellular signal transduction pathways and in their sensitivity to pharmacological agents. Activation of many of these receptors leads to inhibition of postsynaptic Ca2+ and Na+ channels. Unlike the excitatory ionotropic glutamate receptors, mGluRs cause slower postsynaptic responses that can either excite or inhibit postsynaptic cells. As a result, the physiological roles of mGluRs are quite varied.",True,Glutamate receptors,,,,
|
82 |
+
94ea3987-1e6d-4cea-85b1-9d43213d2e4e,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,GABA,False,GABA,,,,
|
83 |
+
466eee53-4364-44de-87f8-c625fdb6645f,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Most inhibitory synapses in the brain and spinal cord use either γ-aminobutyric acid (GABA) or glycine as neurotransmitters. The predominant precursor for GABA synthesis is glucose, which is metabolized to glutamate by the tricarboxylic acid cycle enzymes (figure 2.3). The enzyme glutamic acid decarboxylase (GAD), which is found almost exclusively in GABAergic neurons, catalyzes the conversion of glutamate to GABA. GAD requires pyridoxal phosphate for activity; a deficiency of this vitamin can lead to diminished GABA synthesis.",True,GABA,Figure 2.3,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.3.png,Figure 2.3: Glutamate and GABA synthesis. (α-KG: α-ketoglutarate; PLP: pyridoxal phosphate)
|
84 |
+
0d07f0a5-5274-46d6-a874-1e7b049c9f4f,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Once GABA is synthesized, it is transported into synaptic vesicles via a vesicular inhibitory amino acid transporter (VIAAT). The mechanism of GABA removal is similar to that of glutamate. Both neurons and glia contain high-affinity Na+-dependent cotransporters for GABA, and these cotransporters are termed GATs. Most GABA is eventually converted to succinate, which is metabolized further in the tricarboxylic acid cycle that mediates cellular ATP synthesis.",True,GABA,,,,
|
85 |
+
390b60b9-a56a-4cd8-ab99-9d8ee6bf9d47,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Two mitochondrial enzymes are required for this degradation: GABA transaminase and succinic semialdehyde dehydrogenase.,True,GABA,,,,
|
86 |
+
7555a2ae-d7d4-4547-966d-1b38bfbb599d,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,GABA receptors,False,GABA receptors,,,,
|
87 |
+
c7ca46e5-91be-4a20-bf5c-8e3425d22d40,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"GABAergic synapses employ two types of postsynaptic receptors, called GABAA and GABAB. GABAA are ionotropic receptors, while GABAB are metabotropic receptors. The ionotropic GABAA receptors are GABA-gated anion channels, with Cl– being the main permeant ion under physiological conditions. Thus, activation of these GABA receptors causes an influx of negatively charged Cl– that inhibits postsynaptic cells. The same site binds the hypnotic zolpidem (Ambien), which is widely used to induce sleep. Barbiturates such as phenobarbital and pentobarbital are other hypnotics that also bind to the extracellular domains of the α and β subunits of some GABA receptors and potentiate GABAergic transmission; these drugs are used therapeutically for anesthesia and to control epilepsy. The injection anesthetic ketamine also binds to the extracellular domain of GABA receptors.",True,GABA receptors,,,,
|
88 |
+
fd3a5789-ee2d-4adb-a2d0-e7eff91e4ce8,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"The transmembrane domains of GABAA receptors also serve as the targets for numerous ligands, such as inhalant anesthetics and steroids. Another drug that binds to the transmembrane domain of GABAA receptors is ethanol; at least some aspects of drunken behavior are caused by ethanol-mediated alterations in ionotropic GABA receptors.",True,GABA receptors,,,,
|
89 |
+
7fa812d4-d1c5-4252-ab8d-7f4a7c4c1dff,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"The metabotropic GABAB receptors are also widely distributed in the brain. Like the ionotropic GABA receptors, GABAB receptors are inhibitory. Rather than relying on Cl–-selective channels, however, GABAB-mediated inhibition is often due to the activation of K+ channels and subsequent efflux of K+.",True,GABA receptors,,,,
|
90 |
+
9c83ece4-1e62-4946-b577-f35ba4eb6cd0,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Glycine,False,Glycine,,,,
|
91 |
+
4212e1fe-4eb0-4274-8994-9aaa32a0ac9e,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,The distribution of the neutral amino acid glycine in the CNS is more restricted than that of GABA. About half of the inhibitory synapses in the spinal cord use glycine; most other inhibitory synapses use GABA. Glycine is synthesized from serine by the mitochondrial isoform of serine hydroxymethyltransferase (figure 2.5) and is transported into synaptic vesicles via the same VIAAT that loads GABA into vesicles.,True,Glycine,Figure 2.5,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.5.png,Figure 2.5: GABA and glycine release. (GAT: cotransporters for GABA; VIAAT: vesicular inhibitory amino acid transporter)
|
92 |
+
229898ad-c1e5-4519-8ca6-64b198787192,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Once released from the presynaptic cell, glycine is rapidly removed from the synaptic cleft by glycine transporters in the plasma membrane (figure 2.5).",True,Glycine,Figure 2.5,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.5.png,Figure 2.5: GABA and glycine release. (GAT: cotransporters for GABA; VIAAT: vesicular inhibitory amino acid transporter)
|
93 |
+
108227fe-2ce9-4a48-b9d6-b129dc4a9413,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Glycine receptors,False,Glycine receptors,,,,
|
94 |
+
103cb502-6c1c-495e-81ce-f41dec962706,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Glycine receptors are pentamers consisting of a combination of four types of α subunits, along with an accessory β subunit. These receptors are potently blocked by strychnine, which may account for the toxic properties of this plant alkaloid. Glycine receptors are ligand-gated Cl– channels whose general structure closely mirrors that of the GABAA receptors.",True,Glycine receptors,,,,
|
95 |
+
e66bf022-1fd3-44d6-a2fc-155216978f93,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,2.1: Acetylcholine and the primary amino acid neurotransmitters.,True,Glycine receptors,,,,
|
96 |
+
e33b8d7d-177c-4dac-8790-74fb0ee5242f,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Biogenic amines,False,Biogenic amines,,,,
|
97 |
+
8fa69be5-955b-4ff7-8935-9d6ee69f4321,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Biogenic amine transmitters regulate many brain functions and are also active in the peripheral nervous system. There are five well-established biogenic amine neurotransmitters, three of which can be classified as catecholamines:",True,Biogenic amines,,,,
|
98 |
+
25af2920-e5ff-4f32-8497-993f340afac1,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"1. Dopamine (catecholamine),
|
99 |
+
|
100 |
+
2. Adrenaline/noradrenaline (catecholamine),
|
101 |
+
|
102 |
+
3. Epinephrine/norepinephrine (catecholamine),
|
103 |
+
|
104 |
+
4. Histamine, and
|
105 |
+
|
106 |
+
5. Serotonin.",True,Biogenic amines,,,,
|
107 |
+
4d10797b-6644-469d-b798-8ff52334b1cd,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Dopamine,False,Dopamine,,,,
|
108 |
+
1343fada-6249-4ba2-85b9-6d268bb14384,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,The first step in catecholamine synthesis is catalyzed by tyrosine hydroxylase in a reaction requiring oxygen as a cosubstrate and tetrahydrobiopterin as a cofactor to synthesize dihydroxyphenylalanine (DOPA) (figure 2.6).,True,Dopamine,Figure 2.6,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.6.png,"Figure 2.6: Synthesis of dopamine, norepinephrine, and epinephrine."
|
109 |
+
3df319ec-e98d-4f4e-9ad7-3a586e4ed1be,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Dopamine is produced by the action of DOPA decarboxylase on DOPA. Following its synthesis in the cytoplasm of presynaptic terminals, dopamine is loaded into synaptic vesicles via a vesicular monoamine transporter (VMAT). Dopamine action in the synaptic cleft is terminated by reuptake of dopamine into nerve terminals or surrounding glial cells by a Na+-dependent dopamine cotransporter, termed DAT.",True,Dopamine,,,,
|
110 |
+
a38098f7-94bb-4ac9-a774-556ebf5eb182,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,The two major enzymes involved in the catabolism of dopamine are monoamine oxidase (MAO) and catechol O-methyltransferase (COMT). Both neurons and glia contain mitochondrial MAO and cytoplasmic COMT.,True,Dopamine,,,,
|
111 |
+
0b262f79-55e3-4eb1-8ebe-8734a1aa008a,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Dopamine receptors,False,Dopamine receptors,,,,
|
112 |
+
b51a4662-9d6c-42f2-83fc-8ad2d6beb3a9,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Once released, dopamine acts exclusively by activating G-protein–coupled receptors. Most dopamine receptor subtypes act by either activating or inhibiting adenylyl cyclase. Activation of these receptors generally contributes to complex behaviors.",True,Dopamine receptors,,,,
|
113 |
+
8c9edc66-b93d-4f3e-9f1f-a979b14aa20d,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Norepinephrine (also called noradrenaline) is used as a neurotransmitter and influences sleep and wakefulness, arousal, attention, and feeding behavior. Perhaps the most prominent noradrenergic neurons are sympathetic ganglion cells, which employ norepinephrine as the major peripheral transmitter in this division of the visceral motor system.",True,Dopamine receptors,,,,
|
114 |
+
4905d479-d447-48e6-91eb-1513a0b1325b,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Norepinephrine synthesis requires dopamine β-hydroxylase, which catalyzes the production of norepinephrine from dopamine (figure 2.6). Norepinephrine is then loaded into synaptic vesicles via the same VMAT involved in vesicular dopamine transport.",True,Dopamine receptors,Figure 2.6,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.6.png,"Figure 2.6: Synthesis of dopamine, norepinephrine, and epinephrine."
|
115 |
+
e6fd5437-7024-4040-bbee-425be9e19a84,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Norepinephrine is cleared from the synaptic cleft by the norepinephrine transporter (NET), an Na+-dependent cotransporter that is also capable of taking up dopamine. NET is a molecular target of amphetamine, which acts as a stimulant by producing a net increase in the release of norepinephrine and dopamine. Like dopamine, norepinephrine is degraded by MAO and COMT.",True,Dopamine receptors,,,,
|
116 |
+
d1119468-0f78-46ff-94d8-79d9bf3202e0,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Epinephrine (also called adrenaline) is found in the brain at lower levels than the other catecholamines and is also present in fewer brain neurons than other catecholamines. Epinephrine-secreting neurons regulate respiration and cardiac function. The enzyme that synthesizes epinephrine, phenylethanolamine-N-methyltransferase (figure 2.6), is present only in epinephrine-secreting neurons. Otherwise, the metabolism of epinephrine is very similar to that of norepinephrine. Epinephrine is loaded into vesicles via the VMAT. No plasma membrane transporter specific for epinephrine has been identified, although the NET is capable of transporting epinephrine. As already noted, epinephrine acts on both α- and β-adrenergic receptors.",True,Dopamine receptors,Figure 2.6,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.6.png,"Figure 2.6: Synthesis of dopamine, norepinephrine, and epinephrine."
|
117 |
+
ca74af69-2d38-4961-8f8c-062a7cc1c390,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Epinephrine and norepinephrine signaling,False,Epinephrine and norepinephrine signaling,,,,
|
118 |
+
6ea14edf-bd30-4e46-9fcb-54aff76c2772,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Both norepinephrine and epinephrine act on α- and β-adrenergic receptors. Both types of receptor are G-protein–coupled; in fact, the β-adrenergic receptor was the first identified metabotropic neurotransmitter receptor. Binding of norepinephrine or epinephrine causes small changes in the structure of this receptor, which permits the G-protein to bind. This, in turn, causes larger changes in the shape of the α subunit of the G-protein, the first step in a series of reactions that allow the G-protein to regulate intracellular signaling cascades.",True,Epinephrine and norepinephrine signaling,,,,
|
119 |
+
d510716a-6520-4d52-a58a-2e7e9337962c,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Two subclasses of α-adrenergic receptors have been identified. Activation of α1 – adernergic receptors usually results in a slow depolarization linked to the inhibition of K+ channels, while activation of α2 receptors produces a slow hyperpolarization due to the activation of a different type of K+ channel. There are three subtypes of β-adrenergic receptors, two of which are expressed in many types of neurons.",True,Epinephrine and norepinephrine signaling,,,,
|
120 |
+
1de10a8a-3807-4a74-9e98-513ce9e3331b,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Histamine,False,Histamine,,,,
|
121 |
+
57619371-622c-42a4-b61d-b66dd30f7e78,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Histamine is found in neurons in the hypothalamus that send sparse but widespread projections to almost all regions of the brain and spinal cord. The central histamine projections mediate arousal and attention, similar to central ACh and norepinephrine projections. Histamine also controls the reactivity of the vestibular system. Allergic reactions or tissue damage cause release of histamine from mast cells in the bloodstream. The close proximity of mast cells to blood vessels, together with the potent actions of histamine on blood vessels, raises the possibility that histamine may influence brain blood flow.",True,Histamine,,,,
|
122 |
+
9cdc0fc7-1e2a-42cc-a225-35628c099e68,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Histamine is produced from the amino acid histidine by a histidine decarboxylase (figure 2.7) and is transported into vesicles via the same VMAT as the catecholamines. No plasma membrane histamine transporter has been identified yet.,True,Histamine,Figure 2.7,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.7.png,Figure 2.7: Histamine synthesis.
|
123 |
+
4a5380aa-826d-4eb9-93be-8100dc1c8b53,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Histamine is degraded by the combined actions of histamine methyltransferase and MAO.,True,Histamine,,,,
|
124 |
+
c6a054ee-3bd9-46ed-a413-dff6b91ac9a8,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Histamine receptors,False,Histamine receptors,,,,
|
125 |
+
3367e478-afe0-4f1b-b8fe-c437ce6a7ba8,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"The four known types of histamine receptors are all metabotropic receptors. Of the four, only two of the receptors (H1 and H2) are well characterized. Because of the role of histamine receptors in mediating allergic responses, many histamine receptor antagonists have been developed as antihistamine agents. Antihistamines that cross the blood-brain barrier, such as diphenhydramine (Benadryl), act as sedatives by interfering with the roles of histamine in CNS arousal. Antagonists of the H1 receptor also are used to prevent motion sickness, perhaps because of the role of histamine in controlling vestibular function (figure 2.8).",True,Histamine receptors,Figure 2.8,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.8.png,Figure 2.8: Histamine release and reuptake. (ALDH: aldehyde dehydrogenase; DAO: diamine oxidase; HA: histamine; HNMT: N-methyltransferase; IA: imidazole acetaldehyde; IAA: imidazoleacetic acid; IAAR: imidazoleacetic acid riboside; NMH: N-methylhistamine; N-MIA: methylimidazole acetaldehyde; N-MIAA: N-methylimidazoleacetic acetic acid; OC3: organic cation transporter 3; PMAT: plasma membrane monoamine transporter)
|
126 |
+
21cfb848-a6ba-4241-b66b-0f28a292c8ca,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"H2 receptors control the secretion of gastric acid in the digestive system, allowing H2 receptor antagonists to be used in treating a variety of upper gastrointestinal disorders (e.g., peptic ulcers).",True,Histamine receptors,,,,
|
127 |
+
df484e98-fb72-4aac-8c3d-796bbee43bbd,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Serotonin,False,Serotonin,,,,
|
128 |
+
049c88f5-7e1b-4bcb-9c36-5156c17a5560,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Serotonin, or 5-hydroxytryptamine (5-HT), was initially thought to increase vascular tone by virtue of its presence in blood serum (hence the name serotonin). 5-HT is synthesized from the amino acid tryptophan, which is an essential dietary requirement. Tryptophan is taken up into neurons by a plasma membrane transporter and hydroxylated in a reaction catalyzed by the enzyme tryptophan-5-hydroxylase (figure 2.9), the rate-limiting step for 5-HT synthesis. Loading of 5-HT into synaptic vesicles is done by the VMAT that is also responsible for loading other monoamines into synaptic vesicles. The synaptic effects of serotonin are terminated by transport back into nerve terminals via a specific serotonin transporter (SERT) that is present in the presynaptic plasma membrane and is encoded by the 5HTT gene. Many antidepressant drugs are selective serotonin reuptake inhibitors (SSRIs) that inhibit transport of 5-HT by SERT. Perhaps the best-known example of an SSRI is the antidepressant drug Prozac.",True,Serotonin,Figure 2.9,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.9.png,Figure 2.9: Serotonin synthesis.
|
129 |
+
090b8186-b811-43aa-b66d-159107cdd3b2,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,The primary catabolic pathway for 5-HT is mediated by MAO.,False,The primary catabolic pathway for 5-HT is mediated by MAO.,,,,
|
130 |
+
a72e72f5-fbc5-4e71-9ab8-a5b9accedf37,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Serotonin receptors,False,Serotonin receptors,,,,
|
131 |
+
20c5656e-46d7-4307-8514-9263fb8e1e4b,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Most 5-HT receptors are metabotropic, with a monomeric structure typical of G-protein–coupled receptors. Metabotropic 5-HT receptors have been implicated in a wide range of behaviors, including circadian rhythms, motor behaviors, emotional states, and mental arousal. Impairments in the function of these receptors have been implicated in numerous psychiatric disorders, such as depression, anxiety disorders, and schizophrenia, and drugs acting on serotonin receptors are effective treatments for several of these conditions.",True,Serotonin receptors,,,,
|
132 |
+
49ce8c4a-4a7a-44c0-b6b8-ba379d6cefe8,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,Table 2.2: Summary of neurotransmitter synthesis and degradation.,True,Serotonin receptors,,,,
|
133 |
+
b7209d5e-9da5-4d96-9003-167d7fb55fa1,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,References and resources,False,References and resources,,,,
|
134 |
+
3ef1c28b-edf3-4c7d-8cfe-98104a3884de,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,“Biochemistry of Nerve Transmission.” The Medical Biochemistry Page. http://themedicalbiochemistrypage.or…-transmission/.,True,References and resources,,,,
|
135 |
+
5f067d1d-a9fe-42d5-ba5d-00d875139d3a,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"“Neurotransmitters and Receptors: Different Classes of Neurotransmitters, and Different Types of Receptors They Bind To.” Khan Academy. https://www.khanacademy.org/science/…heir-receptors.",True,References and resources,,,,
|
136 |
+
b089a984-4905-4553-ac7c-e821aae7ce9e,https://pressbooks.lib.vt.edu/neuroscience/,"2. Neurotransmitters — ACh, glutamate, GABA, and glycine",https://pressbooks.lib.vt.edu/neuroscience/chapter/neurotransmitters-ach-glutamate-gaba-and-glycine/,"Purves, D., G. J. Augustine, Dd. Fitzpatrick, L. C. Katz, A.-S. LaMantia, J. O. McNamara, and S. M. Williams, eds. Neuroscience, 2nd ed. Sunderland, MA: Sinauer Associates, 2001, Chapter 6: Neurotransmitters.",True,References and resources,,,,
|
137 |
+
54b79b2a-82e4-4d60-8931-2b5fd438204d,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"As a brief review, glucose is taken up by the brain in an insulin-independent manner. The brain oxidizes glucose under most conditions with the exception of starvation states. Once the glucose is phosphorylated to glucose 6-phosphate (by hexokinase), it has three potential fates (figure 1.1):",True,References and resources,Figure 1.1,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/1.1.png,"Figure 1.1: Potential fates of glucose oxidation. i. Glucose is oxidized to lactate; ii. Glucose is oxidized through the pentose phosphate pathway (PPP); iii. Glucose is stored as glycogen, which only occurs in astrocytes; iv. Pyruvate can be oxidized through the mitochondria but is not a primary fate. (GLUTs: glucose transporters; MCTs: monocarboxylate transporters; TCA: tricarboxylic acid; DHAP: dihydroxyacetone phosphate; GA3P: glyceraldehyde 3-phosphate)"
|
138 |
+
0babe716-7b82-4f49-b785-4b7efcc7d5d3,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"What is unique to the brain is that not all cell types oxidize glucose to the same extent, but there is a tight coupling that exists between cell types to support both energy demand and glutamate-mediated neurotransmission. This compartmentalized, coupled metabolism between neurons and astrocytes is essential for ATP production, neuronal excitability, and adaptations to stress.",True,References and resources,,,,
|
139 |
+
3657c3ea-7aa2-4b93-85f4-ab8eca86a4d2,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"In the context of this chapter, oxidative metabolism refers to the oxidation of a substrate (glucose) through mitochondrial metabolism versus glycolytic metabolism, which refers to the oxidation of glucose to lactate.",True,References and resources,,,,
|
140 |
+
3582281d-f4e1-4294-88e1-0f77fae600ed,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"To support the high energy demands imposed on neurons, they sustain a high rate of oxidative metabolism for ATP production compared to astrocytes. Despite this high rate of mitochondrial metabolism, glucose uptake is reduced when compared to astrocytes, in part due to the use of lactate as an energy source. Neurons show a preference for lactate over glucose when both substrates are present. There are several reasons why sustaining a low glycolytic rate but high oxidative rate is preferred in this tissue:",True,References and resources,,,,
|
141 |
+
977f700d-dda5-42c2-ab14-a789271e1739,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"To accommodate these two processes, neurons preferentially utilize lactate, which can be readily converted to pyruvate and enter the mitochondria (figure 1.2). The lactate required for neuronal metabolism is produced by astrocytic glucose oxidation and is discussed below.",True,References and resources,Figure 1.2,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/1.2.png,Figure 1.2: Comparison of neuron and astrocyte metabolism. (PDH: pyruvate dehydrogenase complex; PKM1/2: pyruvate kinase isoforms M1 and M2; TCA: tricarboxylic acid; DHAP: dihydroxyacetone phosphate; GA3P: glyceraldehyde 3-phosphate)
|
142 |
+
89e6f789-6a08-451a-a265-17bef6af0760,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,Astrocyte metabolism,False,Astrocyte metabolism,,,,
|
143 |
+
32e60e47-dc46-4e3b-868b-8f3e681a257b,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Within the brain, astrocytes outnumber neurons but have reduced demand for ATP. Although astrocytes display lower oxidative rates when compared to neurons, they have elevated glycolytic rates and avidly take up glucose to support this. Astrocytes primarily metabolize glucose to lactate (rather than through mitochondrial metabolism) and release the lactate in the extracellular space. Astrocytes support this glycolytic profile through the alteration of several key glycolytic enzymes.",True,Astrocyte metabolism,,,,
|
144 |
+
8298a29d-97df-4055-afba-3d95e8743a17,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,Astrocyte-mediated neurotransmitter recycling,False,Astrocyte-mediated neurotransmitter recycling,,,,
|
145 |
+
15462cd8-bb7b-4a5a-b88e-0cf73680cdfe,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"To terminate synaptic transmission and maintain neuronal excitability, astrocytes play a key role in the rapid removal of neurotransmitters from the synaptic cleft. The removal of glutamate is specifically critical as this is the primary excitatory neurotransmitter, and overstimulation of glutamate receptors is highly toxic to neurons.",True,Astrocyte-mediated neurotransmitter recycling,,,,
|
146 |
+
79ed036b-ba19-4089-bbda-6b6be86a03a6,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Astrocytes recycle glutamate through sodium-dependent high-affinity glutamate transporters. Following glutamate uptake, astrocytes also play an important role in transferring this neurotransmitter back to neurons. This transfer is achieved by a process called the glutamate-glutamine cycle, which involves both glutamine synthetase (GS) and glutaminase (GLS) (figure 1.3).",True,Astrocyte-mediated neurotransmitter recycling,Figure 1.3,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/1.3.png,Figure 1.3: Lactate and glutamate shuttling between the astrocyte and the neuron. (GS: glutamine synthetase; GLS: glutaminase; LDH: lactate dehydrogenase; EAATs: excitatory amino acid transporters; MCT: monocarboxylate transporter; GluR: glutamate receptor).
|
147 |
+
9f921409-1ffc-45e2-abce-51862667a3ad,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,GLS,False,GLS,,,,
|
148 |
+
70e91072-9ff4-41d3-b022-2dee9f88145f,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"It is also important to note that astrocytes are the only neural cell type expressing pyruvate carboxylase, a key enzyme in the main anaplerotic pathway in the brain. This allows astrocytes to effectively synthesize glutamate from glucose, making them the cell type responsible for the replenishment of brain glutamate.",True,GLS,,,,
|
149 |
+
02e82d58-b3e2-45b9-a0c0-a0b36bb94f28,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,Astrocyte-neuron lactate shuttle,False,Astrocyte-neuron lactate shuttle,,,,
|
150 |
+
c62d3361-ecc2-4fd9-b937-2d04416d02b0,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"To this point, we have addressed the need for lactate in the neuron to sustain high demands for ATP, astrocyte glycolytic activity and elevated glucose uptake, and the role of the astrocyte in glutamate recycling. These three processes are not unrelated, and the juxtaposition in energy needs and glucose uptake between these two cell types can be reconciled when we address the role of the astrocyte-neuron lactate shuttle (ANLS).",True,Astrocyte-neuron lactate shuttle,,,,
|
151 |
+
8472f6a7-e580-464f-949f-eff35404e112,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,ANLS,False,ANLS,,,,
|
152 |
+
004dfd9b-5fce-46df-9972-1b8a2990eaa6,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,The premise of this shuttle is threefold:,False,The premise of this shuttle is threefold:,,,,
|
153 |
+
adec9f56-e2ea-4bc0-8908-d927475ca190,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Finally, lactate can be used as an energy substrate for neurons for oxidative-derived ATP production (figure 1.3).",True,The premise of this shuttle is threefold:,Figure 1.3,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/1.3.png,Figure 1.3: Lactate and glutamate shuttling between the astrocyte and the neuron. (GS: glutamine synthetase; GLS: glutaminase; LDH: lactate dehydrogenase; EAATs: excitatory amino acid transporters; MCT: monocarboxylate transporter; GluR: glutamate receptor).
|
154 |
+
06e8e204-aa61-452a-824e-5837d9e44c4e,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,Astrocyte glycogen stores,False,Astrocyte glycogen stores,,,,
|
155 |
+
bfb4771b-df39-4f74-bc36-5b7ad275fdeb,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Glycogen is the largest energy reserve of the brain and provides a source of glucose that can be rapidly mobilized without ATP. Stores of glycogen in the brain are almost exclusively localized to astrocytes. Again, this observation raises the question as to why the main energy reserve in the brain is found in astrocytes rather than the high-energy-requiring neurons.",True,Astrocyte glycogen stores,,,,
|
156 |
+
16ba72c9-3c9d-40e6-b1dc-93f814a0c670,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Much like the lactate shuttle, glycogen metabolism relies heavily on the interaction between the two cell types to preserve metabolic homeostasis within the brain environment. Glycogen mobilization can support astrocyte metabolism, but it also increases lactate production and the concentration of lactate in the extracellular space. Considering the role of astrocytic glucose-derived lactate in fueling neuronal energy needs, this coupling of these compartmentalized metabolic processes helps preserve the function of each cell type.",True,Astrocyte glycogen stores,,,,
|
157 |
+
ee556d17-dae5-4717-b2ae-ee419f93760d,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Glycogen also has other roles in the normal brain. The amount of glycogen is under dynamic control of neurotransmitters. For example, decreased neuronal activity, such as in sleep, correlates with increased levels of brain glycogen, while an increase in neuronal activity, such as in the awake brain, is associated with a decrease in glycogen levels in active areas.",True,Astrocyte glycogen stores,,,,
|
158 |
+
f6dfddd7-885f-4809-bda7-7f2eef4bb340,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"As a whole, these observations demonstrate that astrocytic glycogen plays an important and active role in complex brain physiological functions, in particular through an astrocyte-to-neuron transfer of energy metabolites in the form of lactate.",True,Astrocyte glycogen stores,,,,
|
159 |
+
a9af23dd-fb73-447f-9827-7b51bf4131f9,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,The role of astrocyte-neuron interactions to reduce oxidative stress,False,The role of astrocyte-neuron interactions to reduce oxidative stress,,,,
|
160 |
+
9f14ac1b-560a-4249-8a0e-f12eadee6a6f,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Oxidative injury is a key feature of several neuropathological conditions such as stroke, traumatic brain injury, and neurodegenerative diseases. There are several factors that contribute to increased brain vulnerability to oxidative stress, including its high rate of oxidative energy metabolism (a process inevitably generating reactive oxygen species (ROS) as a byproduct), its high unsaturated fatty acids content (which are prone to lipid peroxidation), and its relatively low intrinsic antioxidant capacity.",True,The role of astrocyte-neuron interactions to reduce oxidative stress,,,,
|
161 |
+
90f2d3b6-e2d2-4838-8de3-6baf92b2188f,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Although neurons have a higher proportion of oxidative metabolism, they have few defenses against oxidative stress. Astrocytes, alternatively, have significant levels of ROS-detoxifying enzymes, including glutathione, heme oxygenase 1, glutathione peroxidase, glutathione S-transferase, catalase, and thioredoxin reductase. As a result, astrocytes are much more resistant to cellular damage by H2O2, NO, peroxinitrites, and 6-hydroxydopamine compared to neurons.",True,The role of astrocyte-neuron interactions to reduce oxidative stress,,,,
|
162 |
+
3110cec5-a693-4814-bd1d-2c2133d7a8e3,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Astrocytes also play an important protective role for neurons, suggesting that neurons are dependent on the high antioxidant potential of astrocytes for their own defense against oxidative stress.",True,The role of astrocyte-neuron interactions to reduce oxidative stress,,,,
|
163 |
+
baedc85a-3d91-444c-ab5a-6de15c91007c,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"One way in which astrocytes provide protection is through the shuttling of glutathione (GSH) precursors from astrocytes to neurons. GSH—the most abundant antioxidant molecule in the brain—either acts directly as a ROS scavenger or can be used as a substrate for glutathione S-transferase or glutathione peroxidase. Both cell types can synthesize the GSH tripeptide, but neurons are highly dependent on astrocytes for the supply of the precursor amino acids necessary for their own GSH synthesis.",True,The role of astrocyte-neuron interactions to reduce oxidative stress,,,,
|
164 |
+
ad724687-601d-4ecb-8984-84251c9d6046,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"The reduction of peroxides catalyzed by glutathione peroxidase generates glutathione disulfide (GSSG, the oxidized form of GSH). GSH can subsequently be regenerated from GSSG by the action of the enzyme glutathione reductase, using NADPH as an electron donor. This process is essential for the maintenance of GSH in its reduced form, and thus for its availability for the detoxification of ROS. As a consequence, constant NADPH supply is essential for the maintenance of the cellular redox state.",True,The role of astrocyte-neuron interactions to reduce oxidative stress,,,,
|
165 |
+
e6b3e8d8-5ca7-4192-a250-70d417c483c1,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"NADPH production is mainly achieved by the metabolism of glucose via the PPP, thereby coupling glutathione recycling to glucose utilization. NADPH is more abundant in astrocytes than in neurons, and astrocytes have a higher basal PPP activity rate and a better capacity to stimulate this pathway in response to oxidative stress.",True,The role of astrocyte-neuron interactions to reduce oxidative stress,,,,
|
166 |
+
98cabc3c-558b-44db-ae3e-44058c6cb63f,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,Astrocyte-neuron impact on cerebral blood flow,False,Astrocyte-neuron impact on cerebral blood flow,,,,
|
167 |
+
97707d59-bae3-4c25-adc9-07ef971dd8aa,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"The metabolic interplay between astrocytes and neurons goes beyond substrate usage and availability to impact cerebral blood flow through both vasoconstriction and vasodilation. Interestingly, these opposite effects on the vascular tone involve different but parallel signaling cascades in astrocytes.",True,Astrocyte-neuron impact on cerebral blood flow,,,,
|
168 |
+
ab69a214-b411-406c-a3f2-2ec717a0fcd6,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Briefly, neuronal release of glutamate can stimulate the metabotropic glutamate receptors (mGluR) on astrocytes. This in turn activates phospholipase C and increases intracellular calcium. Ca2+ transients in astrocytes activate cytosolic phospholipase A2 (PLA2), thus producing arachidonic acid (AA). AA can be used for the synthesis of prostaglandins, which can have different types of vasodilating effects. In parallel, AA can diffuse to arteriolar smooth muscle cells, where it is converted to 20-hydroxyeicosatetraenoic acid (20-HETE), which has a vasoconstricting effect. Whether the predominant impact on vascular tone is dilation or constriction depends on levels of lactate and adenosine in the extracellular space.",True,Astrocyte-neuron impact on cerebral blood flow,,,,
|
169 |
+
7d485cc1-7189-43de-a3f7-5ddfbc90bf2e,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"During brain activation, consistent with low O2, an increase in lactate in the extracellular space will enhance vasodilation by assisting in the accumulation of prostaglandin E2 (PGE2). Elevated adenosine also enhances vasodilation but through an inhibitory effect on the synthesis of 20-HETE. This is an interesting observation and suggests that cerebral blood flow is largely controlled by glycolytic (vs. oxidative) metabolism and that increased cerebral blood flow correlates with elevations in lactate concentration (rather than O2 consumption).",True,Astrocyte-neuron impact on cerebral blood flow,,,,
|
170 |
+
758f5d52-7ff2-43eb-81d0-e2f06cdb327b,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,References and resources,False,References and resources,,,,
|
171 |
+
cd766723-9078-4cfe-a5af-7e26de693949,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Bélanger, M., I. Allaman, and P. J. Magistretti. “Brain Energy Metabolism: Focus on Astrocyte–Neuron Metabolic Cooperation.” Cell Metabolism 14, no. 6 (December 2011): 724–738, https://doi.org/10.1016/j.cmet.2011.08.016.",True,References and resources,,,,
|
172 |
+
7fd59828-b121-4cf5-9bf5-3e7779c2360c,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Le, T., and V. Bhushan. First Aid for the USMLE Step 1, 29th ed. New York: McGraw Hill Education, 2018, 87, 314–315.",True,References and resources,,,,
|
173 |
+
c3528409-5aee-410f-81f0-443b61264194,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Lieberman, M., and A. Peet, eds. Marks’ Basic Medical Biochemistry: A Clinical Approach, 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2018, Chapter 46: Metabolism of the Nervous System.",True,References and resources,,,,
|
174 |
+
66a8b8c3-3424-4336-9832-393bb4d42d51,https://pressbooks.lib.vt.edu/neuroscience/,1. Neuron and astrocyte metabolism,https://pressbooks.lib.vt.edu/neuroscience/chapter/chapter-1/,"Magistretti, P. J., and I. Allaman. “A Cellular Perspective on Brain Energy Metabolism and Functional Imaging.” Neuron 86, no. 4 (May 2015): 883–901, https://doi.org/10.1016/j.neuron.2015.03.035.",True,References and resources,,,,
|
neuroscience/images/Figure 1.1.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 1.2.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 1.3.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.1.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.2.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.3.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.4.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.5.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.6.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.7.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.8.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 2.9.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 4.1.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 4.3.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 4.4.jpg
ADDED
Git LFS Details
|
neuroscience/images/Figure 4.6.jpg
ADDED
Git LFS Details
|
neuroscience/queries.csv
ADDED
@@ -0,0 +1,22 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
fig_num,sub_section_headings,images-src,image_caption
|
2 |
+
Figure 4.1,Phenylalanine and tyrosine,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.1.png,Figure 4.1: Metabolism of phenylalanine requires BH4 and also produces tyrosine. Deficiencies in cofactor or phenylalanine hydroxylase can result in phenylketonuria.
|
3 |
+
Figure 4.3,Tryptophan,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.3.png,Figure 4.3: Metabolism of tryptophan to melatonin.
|
4 |
+
Figure 4.4,Glutamate,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.4.png,Figure 4.4: Glutamate metabolism as it interfaces with nitrogen transport and synthesis of GABA.
|
5 |
+
Figure 4.6,Methionine,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.6-1.png,Figure 4.6: Metabolism of methionine. Remethylation and transsulfuration of homocysteine are illustrated. Cofactor or enzymatic deficiencies can result in an elevation of homocysteine.
|
6 |
+
Figure 4.6,Transsulfuration pathway,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/4.6-1.png,Figure 4.6: Metabolism of methionine. Remethylation and transsulfuration of homocysteine are illustrated. Cofactor or enzymatic deficiencies can result in an elevation of homocysteine.
|
7 |
+
Figure 2.1,References and resources,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.1.png,Figure 2.1: Synthesis and degradation of acetylcholine.
|
8 |
+
Figure 2.1,Termination of signal,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.1.png,Figure 2.1: Synthesis and degradation of acetylcholine.
|
9 |
+
Figure 2.2,Acetylcholine receptors,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.2.png,Figure 2.2: ACh release and degradation. (A: acetyl-CoA; ACh: acetylcholine; AChE: acetylcholine esterase; Ch: choline; VAChT: vesicular ACh transporter)
|
10 |
+
Figure 2.3,Glutamate,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.3.png,Figure 2.3: Glutamate and GABA synthesis. (α-KG: α-ketoglutarate; PLP: pyridoxal phosphate)
|
11 |
+
Figure 2.4,Glutamate,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.4.png,Figure 2.4: Glutamate release and reuptake. (EAAT: excitatory amino acid transporters)
|
12 |
+
Figure 2.3,GABA,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.3.png,Figure 2.3: Glutamate and GABA synthesis. (α-KG: α-ketoglutarate; PLP: pyridoxal phosphate)
|
13 |
+
Figure 2.5,Glycine,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.5.png,Figure 2.5: GABA and glycine release. (GAT: cotransporters for GABA; VIAAT: vesicular inhibitory amino acid transporter)
|
14 |
+
Figure 2.6,Dopamine,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.6.png,"Figure 2.6: Synthesis of dopamine, norepinephrine, and epinephrine."
|
15 |
+
Figure 2.6,Dopamine receptors,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.6.png,"Figure 2.6: Synthesis of dopamine, norepinephrine, and epinephrine."
|
16 |
+
Figure 2.7,Histamine,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.7.png,Figure 2.7: Histamine synthesis.
|
17 |
+
Figure 2.8,Histamine receptors,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.8.png,Figure 2.8: Histamine release and reuptake. (ALDH: aldehyde dehydrogenase; DAO: diamine oxidase; HA: histamine; HNMT: N-methyltransferase; IA: imidazole acetaldehyde; IAA: imidazoleacetic acid; IAAR: imidazoleacetic acid riboside; NMH: N-methylhistamine; N-MIA: methylimidazole acetaldehyde; N-MIAA: N-methylimidazoleacetic acetic acid; OC3: organic cation transporter 3; PMAT: plasma membrane monoamine transporter)
|
18 |
+
Figure 2.9,Serotonin,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/2.9.png,Figure 2.9: Serotonin synthesis.
|
19 |
+
Figure 1.1,References and resources,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/1.1.png,"Figure 1.1: Potential fates of glucose oxidation. i. Glucose is oxidized to lactate; ii. Glucose is oxidized through the pentose phosphate pathway (PPP); iii. Glucose is stored as glycogen, which only occurs in astrocytes; iv. Pyruvate can be oxidized through the mitochondria but is not a primary fate. (GLUTs: glucose transporters; MCTs: monocarboxylate transporters; TCA: tricarboxylic acid; DHAP: dihydroxyacetone phosphate; GA3P: glyceraldehyde 3-phosphate)"
|
20 |
+
Figure 1.2,References and resources,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/1.2.png,Figure 1.2: Comparison of neuron and astrocyte metabolism. (PDH: pyruvate dehydrogenase complex; PKM1/2: pyruvate kinase isoforms M1 and M2; TCA: tricarboxylic acid; DHAP: dihydroxyacetone phosphate; GA3P: glyceraldehyde 3-phosphate)
|
21 |
+
Figure 1.3,Astrocyte-mediated neurotransmitter recycling,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/1.3.png,Figure 1.3: Lactate and glutamate shuttling between the astrocyte and the neuron. (GS: glutamine synthetase; GLS: glutaminase; LDH: lactate dehydrogenase; EAATs: excitatory amino acid transporters; MCT: monocarboxylate transporter; GluR: glutamate receptor).
|
22 |
+
Figure 1.3,The premise of this shuttle is threefold:,https://pressbooks.lib.vt.edu/app/uploads/sites/68/2022/01/1.3.png,Figure 1.3: Lactate and glutamate shuttling between the astrocyte and the neuron. (GS: glutamine synthetase; GLS: glutaminase; LDH: lactate dehydrogenase; EAATs: excitatory amino acid transporters; MCT: monocarboxylate transporter; GluR: glutamate receptor).
|
neuroscience/scores.csv
ADDED
@@ -0,0 +1,130 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
query,corpus,score
|
2 |
+
Figure 4.1,2b619524-64a0-4412-93bf-1aa6b7e23113,1
|
3 |
+
Figure 4.1,78effb87-80dd-42a6-940d-801ba33f16f9,2
|
4 |
+
Figure 4.1,6778e5ab-6768-4fae-86c7-ee2b6de8164c,2
|
5 |
+
Figure 4.3,4bffc503-a72c-4258-89f6-b7e5db4a7882,1
|
6 |
+
Figure 4.3,dee0215c-7152-4c97-afbd-f0d03484af84,2
|
7 |
+
Figure 4.4,f178b212-e09b-46d1-ab4c-a54f345278ff,1
|
8 |
+
Figure 4.4,62b26cb1-b780-486e-acbc-37dd751b58e7,2
|
9 |
+
Figure 4.4,73a3b896-9aba-4175-835b-6be3de5fc273,1
|
10 |
+
Figure 4.4,24801513-7b21-42ef-bf30-32be372bb1f6,1
|
11 |
+
Figure 4.4,29ebc630-cef4-4261-8494-6ed21b0f0016,1
|
12 |
+
Figure 4.6,916c6c09-60fc-4a2a-a1c1-c22a1bac3b41,1
|
13 |
+
Figure 4.6,ae28d1c5-0c2c-4e59-8391-fb88e7d08cb7,1
|
14 |
+
Figure 4.6,95d35415-03a3-49ae-b442-2827f8f346a1,2
|
15 |
+
Figure 4.6,daf88d9f-8854-4d59-8bc9-cdf287a9ad9d,1
|
16 |
+
Figure 4.6,663b595a-3866-4c1a-8f45-92381705bd10,2
|
17 |
+
Figure 2.1,23ebbb8d-5df4-4b0a-8a86-4dcdc3f34e13,1
|
18 |
+
Figure 2.1,30504ceb-862e-48c1-bc39-4ebd97e7cd2a,1
|
19 |
+
Figure 2.1,f814fbb7-0506-470d-be91-332dc7f6e933,1
|
20 |
+
Figure 2.1,279012c4-5337-4f17-8e30-15c0a30fd0c7,1
|
21 |
+
Figure 2.1,1cb43208-8a51-4579-9c86-2ac4863a85bd,1
|
22 |
+
Figure 2.1,d7d6cf19-589a-4252-8624-0ec808cd0955,1
|
23 |
+
Figure 2.1,43721d34-b597-459d-9a11-fed27bc8628c,1
|
24 |
+
Figure 2.1,474c3f8f-b2a3-4c5e-bac4-e6ab9d814896,2
|
25 |
+
Figure 2.1,b7209d5e-9da5-4d96-9003-167d7fb55fa1,1
|
26 |
+
Figure 2.1,3ef1c28b-edf3-4c7d-8cfe-98104a3884de,1
|
27 |
+
Figure 2.1,5f067d1d-a9fe-42d5-ba5d-00d875139d3a,1
|
28 |
+
Figure 2.1,b089a984-4905-4553-ac7c-e821aae7ce9e,1
|
29 |
+
Figure 2.1,54b79b2a-82e4-4d60-8931-2b5fd438204d,1
|
30 |
+
Figure 2.1,0babe716-7b82-4f49-b785-4b7efcc7d5d3,1
|
31 |
+
Figure 2.1,3657c3ea-7aa2-4b93-85f4-ab8eca86a4d2,1
|
32 |
+
Figure 2.1,3582281d-f4e1-4294-88e1-0f77fae600ed,1
|
33 |
+
Figure 2.1,977f700d-dda5-42c2-ab14-a789271e1739,1
|
34 |
+
Figure 2.1,758f5d52-7ff2-43eb-81d0-e2f06cdb327b,1
|
35 |
+
Figure 2.1,cd766723-9078-4cfe-a5af-7e26de693949,1
|
36 |
+
Figure 2.1,7fd59828-b121-4cf5-9bf5-3e7779c2360c,1
|
37 |
+
Figure 2.1,c3528409-5aee-410f-81f0-443b61264194,1
|
38 |
+
Figure 2.1,66a8b8c3-3424-4336-9832-393bb4d42d51,1
|
39 |
+
Figure 2.1,538d7fe9-a098-45d2-9332-44d3f8d1fd14,1
|
40 |
+
Figure 2.1,daac396d-a353-40f3-a508-88eaa6a86b43,2
|
41 |
+
Figure 2.2,a67fde95-cd32-4a58-aba6-72a33971b121,1
|
42 |
+
Figure 2.2,b4795726-a834-453a-bfea-985baa8478e5,1
|
43 |
+
Figure 2.2,538f2a7f-1632-46c2-8cb1-748638bca19a,2
|
44 |
+
Figure 2.3,f178b212-e09b-46d1-ab4c-a54f345278ff,1
|
45 |
+
Figure 2.3,62b26cb1-b780-486e-acbc-37dd751b58e7,1
|
46 |
+
Figure 2.3,73a3b896-9aba-4175-835b-6be3de5fc273,1
|
47 |
+
Figure 2.3,24801513-7b21-42ef-bf30-32be372bb1f6,2
|
48 |
+
Figure 2.3,29ebc630-cef4-4261-8494-6ed21b0f0016,1
|
49 |
+
Figure 2.4,f178b212-e09b-46d1-ab4c-a54f345278ff,1
|
50 |
+
Figure 2.4,62b26cb1-b780-486e-acbc-37dd751b58e7,1
|
51 |
+
Figure 2.4,73a3b896-9aba-4175-835b-6be3de5fc273,1
|
52 |
+
Figure 2.4,24801513-7b21-42ef-bf30-32be372bb1f6,1
|
53 |
+
Figure 2.4,29ebc630-cef4-4261-8494-6ed21b0f0016,2
|
54 |
+
Figure 2.3,94ea3987-1e6d-4cea-85b1-9d43213d2e4e,1
|
55 |
+
Figure 2.3,466eee53-4364-44de-87f8-c625fdb6645f,2
|
56 |
+
Figure 2.3,0d07f0a5-5274-46d6-a874-1e7b049c9f4f,1
|
57 |
+
Figure 2.3,390b60b9-a56a-4cd8-ab99-9d8ee6bf9d47,1
|
58 |
+
Figure 2.5,c7aa5f15-d71c-4885-a90b-a5e33465f0f6,1
|
59 |
+
Figure 2.5,ec1d3db9-6247-462a-aea3-c2d048bf6d68,1
|
60 |
+
Figure 2.5,9c83ece4-1e62-4946-b577-f35ba4eb6cd0,1
|
61 |
+
Figure 2.5,4212e1fe-4eb0-4274-8994-9aaa32a0ac9e,2
|
62 |
+
Figure 2.5,229898ad-c1e5-4519-8ca6-64b198787192,2
|
63 |
+
Figure 2.6,4d10797b-6644-469d-b798-8ff52334b1cd,1
|
64 |
+
Figure 2.6,1343fada-6249-4ba2-85b9-6d268bb14384,2
|
65 |
+
Figure 2.6,3df319ec-e98d-4f4e-9ad7-3a586e4ed1be,1
|
66 |
+
Figure 2.6,a38098f7-94bb-4ac9-a774-556ebf5eb182,1
|
67 |
+
Figure 2.6,0b262f79-55e3-4eb1-8ebe-8734a1aa008a,1
|
68 |
+
Figure 2.6,b51a4662-9d6c-42f2-83fc-8ad2d6beb3a9,1
|
69 |
+
Figure 2.6,8c9edc66-b93d-4f3e-9f1f-a979b14aa20d,1
|
70 |
+
Figure 2.6,4905d479-d447-48e6-91eb-1513a0b1325b,2
|
71 |
+
Figure 2.6,e6fd5437-7024-4040-bbee-425be9e19a84,1
|
72 |
+
Figure 2.6,d1119468-0f78-46ff-94d8-79d9bf3202e0,2
|
73 |
+
Figure 2.7,1de10a8a-3807-4a74-9e98-513ce9e3331b,1
|
74 |
+
Figure 2.7,57619371-622c-42a4-b61d-b66dd30f7e78,1
|
75 |
+
Figure 2.7,9cdc0fc7-1e2a-42cc-a225-35628c099e68,2
|
76 |
+
Figure 2.7,4a5380aa-826d-4eb9-93be-8100dc1c8b53,1
|
77 |
+
Figure 2.8,c6a054ee-3bd9-46ed-a413-dff6b91ac9a8,1
|
78 |
+
Figure 2.8,3367e478-afe0-4f1b-b8fe-c437ce6a7ba8,2
|
79 |
+
Figure 2.8,21cfb848-a6ba-4241-b66b-0f28a292c8ca,1
|
80 |
+
Figure 2.9,df484e98-fb72-4aac-8c3d-796bbee43bbd,1
|
81 |
+
Figure 2.9,049c88f5-7e1b-4bcb-9c36-5156c17a5560,2
|
82 |
+
Figure 1.1,23ebbb8d-5df4-4b0a-8a86-4dcdc3f34e13,1
|
83 |
+
Figure 1.1,30504ceb-862e-48c1-bc39-4ebd97e7cd2a,1
|
84 |
+
Figure 1.1,f814fbb7-0506-470d-be91-332dc7f6e933,1
|
85 |
+
Figure 1.1,279012c4-5337-4f17-8e30-15c0a30fd0c7,1
|
86 |
+
Figure 1.1,1cb43208-8a51-4579-9c86-2ac4863a85bd,1
|
87 |
+
Figure 1.1,d7d6cf19-589a-4252-8624-0ec808cd0955,1
|
88 |
+
Figure 1.1,43721d34-b597-459d-9a11-fed27bc8628c,1
|
89 |
+
Figure 1.1,474c3f8f-b2a3-4c5e-bac4-e6ab9d814896,1
|
90 |
+
Figure 1.1,b7209d5e-9da5-4d96-9003-167d7fb55fa1,1
|
91 |
+
Figure 1.1,3ef1c28b-edf3-4c7d-8cfe-98104a3884de,1
|
92 |
+
Figure 1.1,5f067d1d-a9fe-42d5-ba5d-00d875139d3a,1
|
93 |
+
Figure 1.1,b089a984-4905-4553-ac7c-e821aae7ce9e,1
|
94 |
+
Figure 1.1,54b79b2a-82e4-4d60-8931-2b5fd438204d,2
|
95 |
+
Figure 1.1,0babe716-7b82-4f49-b785-4b7efcc7d5d3,1
|
96 |
+
Figure 1.1,3657c3ea-7aa2-4b93-85f4-ab8eca86a4d2,1
|
97 |
+
Figure 1.1,3582281d-f4e1-4294-88e1-0f77fae600ed,1
|
98 |
+
Figure 1.1,977f700d-dda5-42c2-ab14-a789271e1739,1
|
99 |
+
Figure 1.1,758f5d52-7ff2-43eb-81d0-e2f06cdb327b,1
|
100 |
+
Figure 1.1,cd766723-9078-4cfe-a5af-7e26de693949,1
|
101 |
+
Figure 1.1,7fd59828-b121-4cf5-9bf5-3e7779c2360c,1
|
102 |
+
Figure 1.1,c3528409-5aee-410f-81f0-443b61264194,1
|
103 |
+
Figure 1.1,66a8b8c3-3424-4336-9832-393bb4d42d51,1
|
104 |
+
Figure 1.2,23ebbb8d-5df4-4b0a-8a86-4dcdc3f34e13,1
|
105 |
+
Figure 1.2,30504ceb-862e-48c1-bc39-4ebd97e7cd2a,1
|
106 |
+
Figure 1.2,f814fbb7-0506-470d-be91-332dc7f6e933,1
|
107 |
+
Figure 1.2,279012c4-5337-4f17-8e30-15c0a30fd0c7,1
|
108 |
+
Figure 1.2,1cb43208-8a51-4579-9c86-2ac4863a85bd,1
|
109 |
+
Figure 1.2,d7d6cf19-589a-4252-8624-0ec808cd0955,1
|
110 |
+
Figure 1.2,43721d34-b597-459d-9a11-fed27bc8628c,1
|
111 |
+
Figure 1.2,474c3f8f-b2a3-4c5e-bac4-e6ab9d814896,1
|
112 |
+
Figure 1.2,b7209d5e-9da5-4d96-9003-167d7fb55fa1,1
|
113 |
+
Figure 1.2,3ef1c28b-edf3-4c7d-8cfe-98104a3884de,1
|
114 |
+
Figure 1.2,5f067d1d-a9fe-42d5-ba5d-00d875139d3a,1
|
115 |
+
Figure 1.2,b089a984-4905-4553-ac7c-e821aae7ce9e,1
|
116 |
+
Figure 1.2,54b79b2a-82e4-4d60-8931-2b5fd438204d,1
|
117 |
+
Figure 1.2,0babe716-7b82-4f49-b785-4b7efcc7d5d3,1
|
118 |
+
Figure 1.2,3657c3ea-7aa2-4b93-85f4-ab8eca86a4d2,1
|
119 |
+
Figure 1.2,3582281d-f4e1-4294-88e1-0f77fae600ed,1
|
120 |
+
Figure 1.2,977f700d-dda5-42c2-ab14-a789271e1739,2
|
121 |
+
Figure 1.2,758f5d52-7ff2-43eb-81d0-e2f06cdb327b,1
|
122 |
+
Figure 1.2,cd766723-9078-4cfe-a5af-7e26de693949,1
|
123 |
+
Figure 1.2,7fd59828-b121-4cf5-9bf5-3e7779c2360c,1
|
124 |
+
Figure 1.2,c3528409-5aee-410f-81f0-443b61264194,1
|
125 |
+
Figure 1.2,66a8b8c3-3424-4336-9832-393bb4d42d51,1
|
126 |
+
Figure 1.3,8298a29d-97df-4055-afba-3d95e8743a17,1
|
127 |
+
Figure 1.3,15462cd8-bb7b-4a5a-b88e-0cf73680cdfe,1
|
128 |
+
Figure 1.3,79ed036b-ba19-4089-bbda-6b6be86a03a6,2
|
129 |
+
Figure 1.3,004dfd9b-5fce-46df-9972-1b8a2990eaa6,1
|
130 |
+
Figure 1.3,adec9f56-e2ea-4bc0-8908-d927475ca190,2
|